OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	problem_complication

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2606998	6/2007	S73-PMC2606998	['when ASSUMING a 20% UNDERREPORTING before Pregnancy, the RECOMMENDATION for Vitamin\u2009E and iron intake was met, but Intake of Folate, Selenium and Vitamin\u2009D remained below ri for non-Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBLEM_COMPLICATION', 20), ('FUTURE_WORK', 57)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007631', 'feeding behavior', 115, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_27568', 'selenium atom', 133, 'selenium'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant')]
PMC2606998	6/2007	S84-PMC2606998	['from this perspective, the most STRIKING result from THIS STUDY was the CONSIDERABLY lower than RECOMMENDED intakes of Folate and Vitamin\u2009D, both before and during Pregnancy, EVEN when PROBABLE UNDERREPORTING was taken INTO ACCOUNT.']	[('ANOMALY_CURIOUS_FINDING', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('ANOMALY_CURIOUS_FINDING', 72), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 175), ('PROBABLE_UNDERSTANDING', 185), ('PROBLEM_COMPLICATION', 194), ('INCOMPLETE_EVIDENCE', 219)]	8	[('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC2290997	4/2008	S14-PMC2290997	['the BEST-KNOWN benefit of sunlight is its ability to boost the body’s Vitamin D supply; MOST cases of Vitamin D deficiency are DUE TO lack of outdoor sun exposure.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 127)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC2290997	4/2008	S104-PMC2290997	['EVEN in the sun-rich environment of the middle east, insufficient Vitamin D is a SEVERE PROBLEM among Breast-Fed infants of women who wear a burqa (a traditional garment that covers the body from Head to Foot), as reported in the february 2003 journal of pediatrics .']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'breast'), ('GO_0007631', 'feeding behavior', 109, 'fed'), ('UBERON_0000033', 'head', 196, 'head'), ('UBERON_0002387', 'pes', 204, 'foot')]
PMC2290997	4/2008	S193-PMC2290997	['NONETHELESS, says lucas, “there are DRAWBACKS to INFERRING that a RELATIONSHIP with any PROXY for the exposure of interest is a RELATIONSHIP with personal uv dose or Vitamin D status.” on the bright side, she adds, our ability to ACCURATELY gauge an Individual’s uv dose history HAS BEEN ENHANCED with the use of silicone rubber casts of the Back of subjects’ Hands.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 279), ('FUTURE_WORK', 288)]	9	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('NCBITaxon_1', 'root', 250, 'individual'), ('UBERON_0001137', 'dorsum', 342, 'back'), ('UBERON_0002398', 'manus', 360, 'hands')]
PMC2581757	11/2008	S45-PMC2581757	['group b initially consisted of a high number of patients who were viewed as being at an INCREASED RISK of preeclampsia BECAUSE of FACTORS such as preeclampsia in a preceding Pregnancy, hellp syndrome, or eclampsia in any past Pregnancy at any Gestational stage, and who were taking additional Vitamin supplement (1000\xa0mg Vitamin C plus 400\xa0iu Vitamin E per day) from the second Trimester of Pregnancy to Delivery as mentioned for the controls (placebo).']	[('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 119), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('GO_0007565', 'female pregnancy', 174, 'pregnancy'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('GO_0007565', 'female pregnancy', 243, 'gestational'), ('CHEBI_33229', 'vitamin (role)', 293, 'vitamin'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin E'), ('GO_0009294', 'DNA mediated transformation', 378, 'trimester'), ('GO_0007565', 'female pregnancy', 391, 'pregnancy'), ('GO_0007567', 'parturition', 404, 'delivery')]
PMC2582131	11/2008	S118-PMC2582131	['HOWEVER, DUE TO the PREDISPOSITION of asian, black, and hispanic women for Insulin resistance and Vitamin D deficiency, IT IS POSSIBLE that adequate Vitamin D status MAY BE even more IMPORTANT in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 166), ('IMPORTANT_CONSIDERATION', 183)]	6	[('PR_000045358', 'insulin family protein', 75, 'insulin'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC2582131	11/2008	S125-PMC2582131	['intervention studies[14],[40]–[44]assessing the EFFECT of Vitamin D and Calcium supplements on Glucose Metabolism among non-Pregnant Individuals have yielded MIXED results, which is AT LEAST PARTLY DUE TO VARIATIONS in the dose of supplementation and the duration of follow up.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('PROBABLE_UNDERSTANDING', 182), ('INCOMPLETE_EVIDENCE', 191), ('PROBLEM_COMPLICATION', 198), ('DIFFICULT_TASK', 205)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 72, 'calcium'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnant'), ('NCBITaxon_1', 'root', 133, 'individuals')]
PMC2685863	5/2009	S17-PMC2685863	['“many obstetricians are oblivious to their patients’ Vitamin D status and FALSELY ASSUME that the miniscule amount of Vitamin D contained in Prenatal Vitamins will meet the needs of their patients,” hollis says.']	[('PROBLEM_COMPLICATION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 150, 'vitamins')]
PMC2779500	11/2009	S44-PMC2779500	['THESE FINDINGS, among others, UNDOUBTEDLY necessitate CONCERN, and have led authors to QUESTION the benefits of universal Vitamin A supplementation for women in hiv-endemic areas [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 30), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('EXPLICIT_QUESTION', 87)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC2779500	11/2009	S46-PMC2779500	['[31] maintain that Prenatal supplementation of Vitamins B, C, and e SHOULD BE continued DUE TO their MANY REPORTED positive EFFECTS on maternal and fetal health.']	[('FUTURE_WORK', 68), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamins B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 47, 'vitamins B'), ('CHEBI_18245', 'carboxylato group', 59, 'C'), ('PR_000004900', 'complement C3', 59, 'C')]
PMC2779500	11/2009	S118-PMC2779500	['moreover, SINCE Ascorbic Acid (Vitamin C) HAS BEEN cited as a KEY H2O2Scavenging antioxidant [40], we use it as our antioxidant for the purpose of parameter estimation.']	[('PROBLEM_COMPLICATION', 10), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 62)]	3	[('CHEBI_22652', 'ascorbic acid', 16, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin C'), ('CHEBI_74359', 'L-alpha-aminobutyrate zwitterion', 66, 'H2O2scavenging')]
PMC2841444	2/2010	S503-PMC2841444	['DUE TO ethical REASONS RECENT RCTS DID NOT include a placebo group, but compared DIFFERENT treatment modes, using Vitamin K status as the primary outcome.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin K')]
PMC3257641	3/2010	S43-PMC3257641	['furthermore, SINCE 25(Oh)D is stored in Adipose Tissue, there is SOME EVIDENCE that obesity is a FURTHER RISK FACTOR for Vitamin D insufficiency.nutrients-02-00389-t001_table 1\n\ncaption (table-wrap): table 1\n\nrisk factors for Vitamin D deficiency.low ambient uvr level high latitude locationwinter season inadequate sun exposure built or indoor environmentextensive clothing cover (e.g., veiled)excess sun avoidance – (shade, sunscreen) host factors dark skin pigmentationold ageobesitymalabsorptive syndromes (e.g., inflammatory Bowel disease)\nMANY STUDIES HAVE REPORTED on the Vitamin D status of Pregnant women, in a range of environments (summarized intable 2, including studies from 1997–2006).']	[('PROBLEM_COMPLICATION', 13), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 558)]	6	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000160', 'intestine', 530, 'bowel'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin D'), ('GO_0007565', 'female pregnancy', 599, 'pregnant')]
PMC3257641	3/2010	S96-PMC3257641	['thus within the offspring of Vitamin D deficient mothers, there was lower Birth weight in those having the ff or ff genotype (where the f Allele is associated with increased Vitamin D Receptor activity [65]), but not in offspring with the ff genotype ( p -value for INTERACTION after adjustment for potential CONFOUNDING FACTORS = 0.02) [66].']	[('SUPERFICIAL_RELATIONSHIP', 266), ('PROBLEM_COMPLICATION', 309)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('SO_0001023', 'allele', 138, 'allele'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 174, 'vitamin D receptor')]
PMC3257641	3/2010	S104-PMC3257641	['excess Vitamin D administration during Pregnancy COULD also POTENTIALLY be of CONCERN.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy')]
PMC3257641	3/2010	S161-PMC3257641	['for these studies, observational studies will NEED to include seasonal variation in Vitamin D status, POTENTIALLY CONFOUNDING by other seasonal factors such as infection, and also deseasonalized interpersonal variation in Ingested Vitamin D or uvr-derived Vitamin D. with regard to these deaseasonalized MARKERS of Vitamin D status, it is highly LIKELY that Vitamin d status in Pregnancy will be CORRELATED with Ingested or uvr-derived Vitamin D exposure for mothers preceding Pregnancy and offspring after Pregnancy.']	[('FUTURE_WORK', 46), ('INCOMPLETE_EVIDENCE', 102), ('PROBLEM_COMPLICATION', 114), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 346), ('SUPERFICIAL_RELATIONSHIP', 396)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007631', 'feeding behavior', 222, 'ingested'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 358, 'vitamin'), ('GO_0007565', 'female pregnancy', 378, 'pregnancy'), ('GO_0007631', 'feeding behavior', 412, 'ingested'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('GO_0007565', 'female pregnancy', 477, 'pregnancy'), ('GO_0007565', 'female pregnancy', 507, 'pregnancy')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2889879	5/2010	S191-PMC2889879	['MISCLASSIFICATION of fish and Pufa or Vitamin D Intake due to measurement ERROR ASSOCIATED with the Food frequency questionnaire is UNAVOIDABLE, BUT GIVEN the study design LIKELY non-differential, and THUS attenuating any TRUE ASSOCIATION.']	[('PROBLEM_COMPLICATION', 0), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 222), ('SUPERFICIAL_RELATIONSHIP', 227)]	10	[('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 30, 'PUFA'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007631', 'feeding behavior', 48, 'intake'), ('CHEBI_33290', 'food', 100, 'food')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S113-PMC2963768	['inferences regarding the DETERMINANTS of infant/toddlers’ Vitamin D status in THIS STUDY were LIMITED, largely BECAUSE of the SMALL sample-size and substantial uniformity with respect to selected maternal clothing and dietary practices.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 94), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 126)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2963768	10/2010	S138-PMC2963768	['beyond rickets, SPECULATION abounds regarding the POTENTIAL Extra-Skeletal CONSEQUENCES of suboptimal Vitamin D status during Foetal Development and infancy.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 50), ('PROBLEM_COMPLICATION', 75)]	3	[('UBERON_0005614', 'lens anterior epithelium', 60, 'extra'), ('UBERON_0004288', 'skeleton', 66, 'skeletal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0060324', 'face development', 126, 'foetal development')]
PMC2963768	10/2010	S142-PMC2963768	['OTHER POSTULATED CONSEQUENCES of Antenatal or infant Vitamin D deficiency include growth faltering (59,60), type 1 diabetes (61), and asthma (62).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 17)]	3	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC2996405	11/2010	S152-PMC2996405	['this adaptation process was compulsory, SINCE Pelvic deformities due to Vitamin D deficiency COULD PREVENT normal Childbirth, BUT it is REASONABLE to SUGGEST that also OTHER molecular mechanisms apart from depigmentation COULD HAVE been subject to selective pressure in order to increase the levels of Vitamin D in the body.']	[('PROBABLE_UNDERSTANDING', 40), ('PROBLEM_COMPLICATION', 40), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 168), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 227)]	10	[('UBERON_0002108', 'small intestine', 46, 'pelvic'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 114, 'childbirth'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC2798111	12/2010	S43-PMC2798111	['use of formula\nbecause of the POTENTIAL CONFOUNDER of proprietary formulas that contain 400\u2009iu/l Vitamin D, each mother was given up to six 4-oz bottles per month of Vitamin D-free formula with the instructions to avoid use of any formula but if there was a need to supplement, the Vitamin D-free formula prepared by mead-johnson, evansville, in was used.']	[('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 40)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC3004407	12/2010	S12-PMC3004407	['THESE FINDINGS RAISE the ISSUE of adequacy of current Vitamin D RECOMMENDATIONS for Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 15), ('PROBLEM_COMPLICATION', 25), ('FUTURE_WORK', 64)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnant')]
PMC3004407	12/2010	S22-PMC3004407	['AS a result of the CONCERN regarding the prevalence of Vitamin D deficiency among Pregnant women receiving care at community health centers, and TO CLARIFY earlier scientific STUDIES which REPORTED that a majority of african-american and hispanic women are Vitamin D deficient [34–40], a cross-sectional study of Pregnant women presenting at a community health center network in south carolina at latitude 32°n was designed and implemented.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 145), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'pregnant')]
PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3034879	12/2010	S201-PMC3034879	['it SEEMS UNLIKELY, THEREFORE, that IMPROVING Vitamin D intake merely in infancy would revert the CONSEQUENCES of POOR Vitamin D status during the Fetal Period.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('FUTURE_WORK', 35), ('PROBLEM_COMPLICATION', 97), ('IMPORTANT_CONSIDERATION', 113)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 146, 'fetal period')]
PMC3169551	9/2011	S131-PMC3169551	['mean cost per beneficiary were calculated as usd1.95 (Vitamin A), usd3.64 (Iodine), usd0.52 (zinc – ONLY 1 program), BUT WAS NOT calculated for iron.']	[('INCOMPLETE_EVIDENCE', 100), ('PROBLEM_COMPLICATION', 117), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 75, 'iodine')]
PMC3271033	1/2012	S21-PMC3271033	['furthermore, FEW DATA have EVALUATED hispanic infants who MAY BE at high-risk for low Vitamin D status DUE TO POOR maternal Vitamin D intake [4].']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 58), ('PROBABLE_UNDERSTANDING', 103), ('PROBLEM_COMPLICATION', 110)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3296991	2/2012	S0-PMC3296991	['EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, Cord Parathyroid Hormone and bone-specific alkaline phosphatase, and newborn Whole body bone Mineral content\n\nabstract\nin SPITE of a high prevalence of Vitamin D inadequacy in Pregnant women and neonates, RELATIONSHIPS among Vitamin D status (25(Oh)D), Parathyroid hormone (pth), bone specific alkaline phosphatase (balp), and Whole body bone Mineral content (wbbmc) in the newborn are POORLY characterized.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('ANOMALY_CURIOUS_FINDING', 187), ('SUPERFICIAL_RELATIONSHIP', 270), ('PROBLEM_COMPLICATION', 451)]	5	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('UBERON_0000948', 'heart', 65, 'Cord'), ('UBERON_0001132', 'parathyroid gland', 70, 'Parathyroid'), ('CHEBI_5762', 'hordatine A', 82, 'Hormone'), ('UBERON_0004043', 'semicircular canal ampulla', 142, 'Whole'), ('CHEBI_46662', 'mineral', 158, 'Mineral'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 308, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 318, 'parathyroid'), ('UBERON_0007688', 'anlage', 392, 'whole'), ('CHEBI_46662', 'mineral', 408, 'mineral')]
PMC3296991	2/2012	S10-PMC3296991	['HOWEVER, the behavior of these BIOMARKERS in the fetus and their RELATIONSHIP with Vitamin D status and neonatal bone mineralization are POORLY characterized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBLEM_COMPLICATION', 137)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3313761	3/2012	S18-PMC3313761	['hypocalcemia HAS also BEEN shown to occur in exclusively Breast Fed babies not exposed to sunlight and in infants whose mothers are deficient in Vitamin D.[1] symptoms of hypocalcemia in children include lethargy, recurrent Respiratory Tract infections, focal clonic seizures, jitteriness, carpopedal spasm and RARELY stridor DUE TO laryngospasm.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 311), ('PROBLEM_COMPLICATION', 326)]	3	[('GO_0007567', 'parturition', 57, 'breast'), ('UBERON_0000310', 'breast', 57, 'breast'), ('GO_0007631', 'feeding behavior', 64, 'fed'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 224, 'respiratory tract')]
PMC3347028	3/2012	S97-PMC3347028	['WHILE okonofua, et al, SUGGEST that normalization of maternal calcium and pth would be useful endpoints in determining the success of Vitamin D supplementation during Pregnancy, more RECENT STUDIES SUGGEST that BECAUSE pth threshold ESTIMATES cannot be precisely defined, total circulating 25(Oh)D ALONE is a BETTER measure of maternal Vitamin D status [60,64,65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 198), ('PROBLEM_COMPLICATION', 211), ('INCOMPLETE_EVIDENCE', 233), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 298), ('INCOMPLETE_EVIDENCE', 309)]	9	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC3347028	3/2012	S140-PMC3347028	['for those areas of the world with higher rates of deficiency, it APPEARS that a long-standing unawareness of HOW Vitamin D is made and of the short and long-term health CONSEQUENCES of Vitamin D insufficiency has LED TO widespread insufficiencies in most populations.']	[('ANOMALY_CURIOUS_FINDING', 65), ('EXPLICIT_QUESTION', 109), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 213)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S180-PMC3347028	['SINCE the modern diet supplies less than 10% of one’s total Vitamin D REQUIREMENTS, IF judicious sunlight exposure is not an option, then the only alternative for the Pregnant woman is Vitamin D supplementation.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnant'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S183-PMC3347028	['the studies that were available in a cochrane review more than a decade ago INDICATED that the adequate intake (Ai) for Vitamin D during Pregnancy of 400 iu/day is grossly INADEQUATE, especially with ethnic minorities [147].']	[('INCOMPLETE_EVIDENCE', 76), ('PROBLEM_COMPLICATION', 172)]	2	[('CHEBI_28741', 'sodium fluoride', 112, 'AI'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy')]
PMC3347028	3/2012	S191-PMC3347028	['EVEN in the latter trial where women were randomized to either 2000 iu (50 μg) or 4000 iu (100 μg) Vitamin D3/day, there were no safety ISSUES surrounding Vitamin D supplementation and there was a TREND where specific health COMPLICATIONS of Pregnancy such as Preterm Birth, Preterm Labor, hypertensive orders of Pregnancy, Gestational diabetes, and infection were higher in the 400 iu-compared with the 4000 iu-group, but did not reach statistical significance [149].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 136), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 225), ('PROBLEM_COMPLICATION', 225)]	6	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 260, 'preterm birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 275, 'preterm labor'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('GO_0007565', 'female pregnancy', 324, 'gestational')]
PMC3347007	4/2012	S20-PMC3347007	['OTHER SUGGESTED CONSEQUENCES of Vitamin D deficiency during Pregnancy are increased risks of: schizophrenia, type 1 diabetes, multiple sclerosis, Heart disease, cancer, and small for Gestational age diagnosis [10,11,12,13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 16)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0000948', 'heart', 146, 'heart'), ('GO_0007565', 'female pregnancy', 183, 'gestational')]
PMC3347007	4/2012	S40-PMC3347007	['after exclusion of participants with MISSING information on dietary Vitamin D intake, our study population consisted of 68,447 Pregnancies from all over denmark.']	[('PROBLEM_COMPLICATION', 37)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancies')]
PMC3347007	4/2012	S178-PMC3347007	['IT IS POSSIBLE that null value IMPUTATION has caused an UNDERESTIMATION of Vitamin D supplementation, BUT since the ESTIMATED use of Vitamin D supplements is SIMILAR TO the one SEEN in norway [17], and lower than the one in finland [27], we do not think this ISSUE is RELEVANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('PROBLEM_COMPLICATION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 177), ('PROBLEM_COMPLICATION', 259), ('IMPORTANT_CONSIDERATION', 268)]	9	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3348565	4/2012	S23-PMC3348565	['in children, Serum Calcifediol concentrations SHOULD BE maintained at 50 nmol/l (20 ng/ml) or greater for Skeletal benefits.6vitamin D deficiency rickets in children younger than 5 years is an endemic PROBLEM in developing countries, ranging from 5–45%, EVEN where sunlight is abundant,1,2,7,8and has also re-emerged in SOME developed countries.7,9\nin People, the main source of Vitamin D is through the action of ultraviolet b radiation on 7-Dehydrocholesterol in the skin, with small amounts derived from dietary sources.']	[('FUTURE_WORK', 46), ('PROBLEM_COMPLICATION', 201), ('ANOMALY_CURIOUS_FINDING', 254), ('INCOMPLETE_EVIDENCE', 320)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 19, 'calcifediol'), ('UBERON_0004288', 'skeleton', 106, 'skeletal'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('NCBITaxon_10088', 'Mus <genus>', 352, 'people'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 441, '7-dehydrocholesterol')]
PMC3348565	4/2012	S25-PMC3348565	['THEREFORE, Breastmilk, a normally POOR source of Vitamin D,11becomes EVEN more deficient.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 34), ('ANOMALY_CURIOUS_FINDING', 69)]	3	[('UBERON_0001348', 'brown adipose tissue', 11, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3348565	4/2012	S110-PMC3348565	['THUS the LACK OF a PROTECTIVE EFFECT of Vitamin D against pneumonia is PROBABLY not due to MISCLASSIFICATION of outcomes or INADEQUATE supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 71), ('PROBLEM_COMPLICATION', 91), ('PROBLEM_COMPLICATION', 124)]	7	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3348565	4/2012	S120-PMC3348565	['it can be ARGUED that a steady-state adequate Vitamin D concentration was not reached in SOME children BECAUSE of fluctuations in Serum concentrations DUE TO our study regimen.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 89), ('PROBLEM_COMPLICATION', 103), ('PROBLEM_COMPLICATION', 151)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum')]
PMC3348565	4/2012	S129-PMC3348565	['an ASSOCIATED ISSUE is that, after the start of our trial, SPECULATIONS arose that high fluctuations of natural or supplemented Vitamin D intake MIGHT be LINKED to negative outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('PROBLEM_COMPLICATION', 14), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 154)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3348565	4/2012	S130-PMC3348565	['these SPECULATIONS RELATE two studies in which supplementation of a single large dose (300\u200800033or 500\u200800023iu) of Vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar DISCREPANCIES in Prostate cancer research with Vitamin D.22our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin d group COULD BE DUE TO such fluctuations IF the HYPOTHESIS is TRUE.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('INCOMPLETE_EVIDENCE', 372), ('PROBLEM_COMPLICATION', 381), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 406), ('INCOMPLETE_EVIDENCE', 413), ('PROBABLE_UNDERSTANDING', 427)]	8	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 228, 'prostate'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3348565	4/2012	S138-PMC3348565	['ALTHOUGH Vitamin D overload is a theoretical POSSIBILITY, 100\u2008000 iu of Vitamin D3Has BEEN shown to provide the best protection against Vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of Vitamin D.16furthermore, single intramuscular injection of three times this dose (300\u2008000 iu) was safe in treating nutritional rickets in 6–30-month-old children residing in lower socioeconomic regions of sunny istanbul.35higher than RECOMMENDED doses of daily supplementation of Vitamin D (500–1000 iu per day, adding up to 120\u2008000 iu over 3 months) plus additional milk fortified with Vitamin D, HAS BEEN shown not to induce an overload,13including in infants starting with normal ranges of Vitamin D, EVEN when supplementation continued during the summer (in france) and when mothers had Antenatal Vitamin D supplementation.36it is IMPORTANT to note that in our study, where community supplementation was in a population with known high rates of Vitamin D deficiency, 1% of children tested had a Calcifediol concentration greater than 375 nmol/l—THOUGHT UNDESIRABLY high.6ALTHOUGH these did not produce any clinical signs and symptoms, these measurements raise a NEED for CAUTION with doses for population supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 492), ('INCOMPLETE_EVIDENCE', 656), ('ANOMALY_CURIOUS_FINDING', 762), ('IMPORTANT_CONSIDERATION', 893), ('INCOMPLETE_EVIDENCE', 1107), ('PROBLEM_COMPLICATION', 1115), ('ANOMALY_CURIOUS_FINDING', 1133), ('FUTURE_WORK', 1224), ('IMPORTANT_CONSIDERATION', 1233)]	12	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_35646', 'galanthan', 72, 'vitamin D3has'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 72, 'vitamin D3has'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 538, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 645, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 751, 'vitamin D'), ('GO_0007567', 'parturition', 849, 'antenatal'), ('CHEBI_27300', 'vitamin D', 859, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1007, 'vitamin D'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 1057, 'calcifediol')]
PMC3356951	4/2012	S3-PMC3356951	['high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('ANOMALY_CURIOUS_FINDING', 48), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 85), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 135)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'D')]
PMC3356951	4/2012	S15-PMC3356951	['black People Absorb more uvb in the Melanin of their skin than do white People and, THEREFORE, require more sun exposure to produce the same amount of vitamin D.[4]\nthe high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('PROBABLE_UNDERSTANDING', 84), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 230), ('IMPORTANT_CONSIDERATION', 240), ('PROBLEM_COMPLICATION', 254), ('PROBABLE_UNDERSTANDING', 260), ('SUPERFICIAL_RELATIONSHIP', 292), ('SUPERFICIAL_RELATIONSHIP', 304)]	8	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('GO_0040011', 'locomotion', 13, 'absorb'), ('CHEBI_25179', 'melanins', 36, 'melanin'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'people'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 159, 'D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D')]
PMC3427192	4/2012	S42-PMC3427192	['studies of Vitamin D status in school-age children with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsbrehm412009616 (60)8.7cross-sectionalmild-to-severe persistent asthmaasthma exacerbationsincreased 25(Oh)D ASSOCIATED with reduced hospitalization, reduced Anti-Inflammatory Medication use and reduced Airway hyperresponsivenessbrehm6920101024 (60)8.9prospective cohortmild-to-moderate persistent asthmahospitalization or emergency Department visitbaseline 25(Oh)D levels < 30 ng/ml ASSOCIATED with higher odds of hospitalization or emergency department over 4 ychinellato70201175 (60)9.6cross-sectionalwell-controlled and POORLY controlled asthmaspirometry, asthma controlpositive CORRELATIONS NOTED between 25(Oh)d and asthma controlchinellato71201145 (60)10cross-sectionalintermittent asthmalung function and Airway hyperresponsivenesslower Serum 25(Oh)D ASSOCIATED with decreased Lung function and increased Airway hyperresponsiveness with exercisefreishtat72201092 (63)11.1cross-sectionalafrican americans with and without asthmaphysician-diagnosed asthmadecreased 25(Oh)D in asthmatics vs. controlsmajak73201148 (67)11.5randomized, double-blind, parallel arm clinical trialnewly diagnosed asthmaasthma exacerbationsfewer exacerbations in children with Vitamin D3Supplementation added to inhaled Budesonidesearing742010100 (64)7cross-sectionalmoderate to severe persistent asthmacorticosteroid use and Airflow limitationdecreased 25(Oh)D ASSOCIATED with lower Lung function and higher Corticosteroid requirementsurashima752010217 (57)10.0randomized, double-blind clinical trialschoolchildren (allcomers), subgroup with physician-diagnosed asthmaasthma exacerbationsreduced risk of asthma exacerbations in the subgroup with asthma after Vitamin D3Supplementation\nother cross-sectional studies of Vitamin D status have also examined the ASSOCIATIONS between 25(Oh)D concentrations and asthma Control in school-age children.']	[('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 516), ('PROBLEM_COMPLICATION', 656), ('SUPERFICIAL_RELATIONSHIP', 715), ('ANOMALY_CURIOUS_FINDING', 728), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1476), ('SUPERFICIAL_RELATIONSHIP', 1873)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH)D'), ('CHEBI_60426', 'dioleoyl phosphatidylglycerol', 290, 'anti-inflammatory medication'), ('UBERON_0001005', 'respiratory airway', 335, 'airway'), ('UBERON_0008247', 'tube foot', 465, 'department'), ('CHEBI_71657', 'versiconol acetate', 490, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 490, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 742, '25(OH'), ('UBERON_0001005', 'respiratory airway', 845, 'airway'), ('UBERON_0001977', 'blood serum', 877, 'serum'), ('CHEBI_71657', 'versiconol acetate', 883, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 885, '(OH ... D'), ('UBERON_0002048', 'lung', 917, 'lung'), ('UBERON_0001005', 'respiratory airway', 945, 'airway'), ('CHEBI_71657', 'versiconol acetate', 1103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1103, '25(OH)D'), ('CHEBI_52915', 'phosphatediyl group', 1291, 'vitamin D3supplementation'), ('CHEBI_72362', 'phosphatidylethanolamine 44:1-OH', 1334, 'budesonideSearing742010100'), ('UBERON_0001005', 'respiratory airway', 1440, 'airflow'), ('CHEBI_71657', 'versiconol acetate', 1468, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1468, '25(OH)D'), ('UBERON_0002048', 'lung', 1498, 'lung'), ('CHEBI_36916', 'cation', 1523, 'corticosteroid'), ('CHEBI_52915', 'phosphatediyl group', 1774, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 1833, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1894, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1900, 'D'), ('GO_0065007', 'biological regulation', 1928, 'control')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3427192	4/2012	S70-PMC3427192	['BECAUSE of the LIMITATIONS of OBSERVATIONAL studies which include CONFOUNDING by indication, definitive RECOMMENDATIONS for Vitamin D in subjects with asthma across the Lifespan cannot be made.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 66), ('FUTURE_WORK', 104)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0000104', 'life cycle', 169, 'lifespan')]
PMC3427250	8/2012	S31-PMC3427250	['there is a GROWING CONCERN about the health CONSEQUENCES of the high prevalence of Vitamin D deficiency worldwide among the general population, including Pregnant women.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 44)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
PMC3427250	8/2012	S122-PMC3427250	['in addition to the UNCERTAINTY CONCERNING the optimal Vitamin D intakes preventing Vitamin D deficiency, there exists also a LACK OF RECOMMENDATIONS to treat Vitamin D deficient Pregnant women.']	[('FULL_UNKNOWN', 19), ('PROBLEM_COMPLICATION', 31), ('INCOMPLETE_EVIDENCE', 125), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC3427250	8/2012	S124-PMC3427250	['the UNCOVERING of the magnitude of Vitamin D deficiency in Pregnant women in belgium (and western europe) SHOULD BE translated into NEW RESEARCH in order to fill the huge KNOWLEDGE GAP CONCERNING the adequate amount of Vitamin D to prevent and treat Vitamin D deficient Pregnant women.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 132), ('FULL_UNKNOWN', 171), ('PROBLEM_COMPLICATION', 185)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0007565', 'female pregnancy', 270, 'pregnant')]
PMC3427250	8/2012	S128-PMC3427250	['the current Vitamin D RECOMMENDATIONS for Pregnant women are clearly INSUFFICIENT to prevent and EVEN more to treat Vitamin D deficient Pregnant women.']	[('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 69), ('ANOMALY_CURIOUS_FINDING', 97)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnant')]
PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3465343	10/2012	S177-PMC3465343	['GIVEN that vad is STILL a SERIOUS and PREVALENT PUBLIC HEALTH PROBLEM in the world especially among Pregnant women and children and dietary Vitamin A is ONLY available from limited sources, including vegetables in the form of Β-Carotene or meat as Retinyl Esters, vad MAY BE an IMPORTANT cause of Human congenital Spinal deformities[43].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 48), ('PROBLEM_COMPLICATION', 62), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 268), ('IMPORTANT_CONSIDERATION', 278)]	9	[('GO_0007565', 'female pregnancy', 100, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 226, 'β-carotene'), ('CHEBI_26523', 'reactive oxygen species', 248, 'retinyl esters'), ('NCBITaxon_9606', 'Homo sapiens', 297, 'human'), ('UBERON_0001130', 'vertebral column', 314, 'spinal')]
PMC3488410	10/2012	S5-PMC3488410	['we will specifically discuss the Vitamin D deficiency MODEL, the poly i:c MODEL, the Ketamine MODEL, and the Postnatal Ventral Hippocampal lesion MODEL, all of which REFLECT core Neurodevelopmental ISSUES UNDERLYING schizophrenia onset.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 166), ('IMPORTANT_CONSIDERATION', 198), ('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_6121', 'ketamine', 85, 'ketamine'), ('GO_0007567', 'parturition', 109, 'postnatal'), ('UBERON_0000218', 'vertebral arch of axis', 119, 'ventral hippocampal'), ('GO_0007399', 'nervous system development', 179, 'neurodevelopmental')]
PMC3488410	10/2012	S138-PMC3488410	['it is also PLAUSIBLE that there is SOME kind of exhaustion of the mitotic cell potency DUE TO the overshooting activity in young Animals, as it was DEMONSTRATED for the Vitamin D deficiency MODEL [131] and the nos knock-out MODEL [138].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 35), ('PROBLEM_COMPLICATION', 87), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 224)]	6	[('NCBITaxon_33208', 'Metazoa', 129, 'animals'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3509518	11/2012	S93-PMC3509518	['SINCE many mothers did not meet the rdi for Vitamin E and Zinc [18], we INVESTIGATED ASSOCIATIONS between Vitamin E and zinc intakes dichotomized as exposure at the minimum rdi (yes/no) and allergic outcomes.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 58, 'Zinc'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin E')]
PMC3515553	12/2012	S4-PMC3515553	['observationally, there was a positive ASSOCIATION between maternal Vitamin B-12 intake and child’s iq that was markedly attenuated after adjustment for potential CONFOUNDERS (mean difference in offspring iq score per doubling of maternal B-12 Intake, before adjustment: 2.0 (95% ci 1.3, 2.8); after adjustment: 0.7 (95% ci −0.04, 1.4)).']	[('SUPERFICIAL_RELATIONSHIP', 38), ('PROBLEM_COMPLICATION', 162)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 67, 'vitamin B-12'), ('PR_000004770', 'Polycomb complex protein BMI-1', 238, 'B-12'), ('GO_0007631', 'feeding behavior', 243, 'intake')]
PMC3515553	12/2012	S18-PMC3515553	['ONE WAY to avoid PROBLEMS of residual CONFOUNDING in OBSERVATIONAL epidemiology is to use Genetic variants that are KNOWN to be reliably RELATED to the modifiable risk factor of interest (here maternal Vitamin B-12) as PROXIES IN ORDER TO determine the causal EFFECT of the risk factor[9],[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 17), ('PROBLEM_COMPLICATION', 38), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 219), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 236), ('SUPERFICIAL_RELATIONSHIP', 260)]	10	[('SO_0000704', 'gene', 90, 'genetic'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 202, 'vitamin B-12')]
PMC3515553	12/2012	S49-PMC3515553	['potential confounders and mediators\nwe TESTED for the ASSOCIATION of POTENTIAL CONFOUNDERS with offspring iq, maternal dietary Vitamin B-12 intake and genotypes of Vitamin B-12 RELATED variants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 69), ('PROBLEM_COMPLICATION', 79), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 164, 'vitamin B-12')]
PMC3515553	12/2012	S65-PMC3515553	['we INVESTIGATED the ASSOCIATION of POTENTIAL CONFOUNDING FACTORS with maternal Vitamin B-12 intake, offspring iq, and maternal and offspring genotype using linear regression and chi square tests.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 35), ('PROBLEM_COMPLICATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 79, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 89, '12')]
PMC3515553	12/2012	S87-PMC3515553	['subsequent adjustment for POTENTIAL CONFOUNDERS attenuated the ASSOCIATION by 65% (model 2), such that in this model offspring iq was on average 0.7 (95%ci −0.04, 1.4; p\u200a=\u200a0.06) points greater per doubling of maternal Vitamin B-12.']	[('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 36), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('CHEBI_27300', 'vitamin D', 218, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 218, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 228, '12')]
PMC3515553	12/2012	S119-PMC3515553	['maternal dietary intake of Vitamin B-12 was ASSOCIATED with the MAJORITY (7 out of 11 (64%)) of POTENTIAL CONFOUNDERS and with two of the three Mediators tested (table s7).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 96), ('PROBLEM_COMPLICATION', 106)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 27, 'vitamin B-12'), ('CHEBI_35222', 'inhibitor', 144, 'mediators')]
PMC3515553	12/2012	S135-PMC3515553	['FINDINGS in the context of existing literature\ntcn2 rs1801198 was ASSOCIATED with maternal Vitamin B-12 Consumption, with heterozygotes showing a higher intake than both homozygotes, ALTHOUGH this COULD WELL be a chance FINDING SINCE this Snp’s PUTATIVE action has not been RELATED to Intake[13].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 220), ('PROBLEM_COMPLICATION', 228), ('PROBABLE_UNDERSTANDING', 245), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 104, 'consumption'), ('SO_0000694', 'SNP', 239, 'SNP'), ('GO_0007631', 'feeding behavior', 285, 'intake')]
PMC3515553	12/2012	S141-PMC3515553	['SINCE h. pylori infection MAY cause Malabsorption of Vitamin B-12, non-secretors are HYPOTHESIZED to have better absorption and HENCE higher Plasma concentrations of vitamin B-12 than secretors[33].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 128)]	5	[('GO_0046693', 'sperm storage', 36, 'malabsorption'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 53, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('PR_000004770', 'Polycomb complex protein BMI-1', 174, 'B-12')]
PMC3515553	12/2012	S156-PMC3515553	['two studies conducted in india, that measured Vitamin B-12 concentration, REPORTED CONTRADICTORY results, POSSIBLY DUE TO DIFFERING levels of Vitamin B-12 deficiency between the populations[6],[8].']	[('INCOMPLETE_EVIDENCE', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 115), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 46, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 142, 'vitamin B-12')]
PMC3515553	12/2012	S169-PMC3515553	['the differences in CONFOUNDERS between sample subsets and the overall alspac sample are UNLIKELY to AFFECT the ASSOCIATION between genotypes and Cord Blood Vitamin B-12 or genotypes and iq because, as EXPECTED, there was no association between genotypes and POTENTIAL CONFOUNDERS, OTHER than what MAY have arisen by chance DUE TO performing a large number of tests on the data.']	[('PROBLEM_COMPLICATION', 19), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('PROBLEM_COMPLICATION', 268), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('INCOMPLETE_EVIDENCE', 297), ('PROBLEM_COMPLICATION', 323)]	10	[('UBERON_0002240', 'spinal cord', 145, 'cord'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 156, 'vitamin B-12')]
PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]
PMC3552819	12/2012	S115-PMC3552819	['two other aes resolved without COMPLICATIONS and occurred in the absence of evidence of Vitamin D toxicity (table\u20093).']	[('PROBLEM_COMPLICATION', 31)]	1	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3552819	12/2012	S218-PMC3552819	['these erratic PATTERNS COULD NOT EASILY BE EXPLAINED on THE BASIS OF KNOWN Vitamin D pharmacokinetics, but were MOST LIKELY ATTRIBUTABLE TO small-sample ARTIFACTS, biological variability in the absorption and Metabolism Of Vitamin D, and inherent imprecision in the laboratory assessment of [25(Oh)D].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('DIFFICULT_TASK', 23), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 137), ('PROBLEM_COMPLICATION', 153)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 209, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 292, '25(OH)D')]
PMC3659910	1/2013	S65-PMC3659910	['methods are CURRENTLY available to quantify the CONTRIBUTION of Endogenous Vitamin D Synthesis resulting from sun exposure, BUT SERIOUS LIMITATIONS REMAIN in ACCURATELY ESTIMATING dietary Vitamin D intake BECAUSE of the INCOMPLETENESS of Nutrient databases for both Vitamin D-fortified Food and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 124), ('IMPORTANT_CONSIDERATION', 128), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 205), ('INCOMPLETE_EVIDENCE', 220)]	10	[('GO_0009790', 'embryo development', 64, 'endogenous'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 75, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33284', 'nutrient', 238, 'nutrient'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3659910	1/2013	S125-PMC3659910	['data from three trials involving 463 women SHOW a TREND for women who receive Vitamin D supplementation during Pregnancy to more frequently have a baby with a Birth weight below 2500 grams than those women receiving no treatment or placebo, ALTHOUGH the statistical significance was borderline.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 50), ('PROBLEM_COMPLICATION', 241)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('GO_0007567', 'parturition', 159, 'birth')]
PMC3659910	1/2013	S161-PMC3659910	['[44] ALTHOUGH 1,25(Oh) 2D is the active circulating form of Vitamin D, measuring this level is NOT HELPFUL BECAUSE it is quickly and tightly Regulated by the Kidney.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('DIFFICULT_TASK', 95), ('PROBLEM_COMPLICATION', 107)]	3	[('CHEBI_37983', 'sulfur-35 atom', 14, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 16, '25(OH) 2D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 68, 'D'), ('GO_0065007', 'biological regulation', 141, 'regulated'), ('UBERON_0002113', 'kidney', 158, 'kidney')]
PMC3659910	1/2013	S163-PMC3659910	['a large laboratory (quest diagnostics) RECENTLY REPORTED the POSSIBILITY of thousands of INCORRECT Vitamin D level results.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC3659910	1/2013	S169-PMC3659910	['as was RECENTLY POINTED out in a cochrane review, the topic of maternal Vitamin D REQUIREMENTS during Pregnancy HAS BEEN POORLY studied.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 112), ('PROBLEM_COMPLICATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC3901983	1/2013	S102-PMC3901983	['an additional CONCERNING ISSUE is Vitamin K deficiency.']	[('IMPORTANT_CONSIDERATION', 14), ('PROBLEM_COMPLICATION', 14), ('PROBLEM_COMPLICATION', 25)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin K')]
PMC3901983	1/2013	S162-PMC3901983	['it is ESSENTIAL to maintain Micronutrients supplementation also after Delivery and during breastfeeding, to ensure appropriate Vitamins and Minerals intake to neonate and to prevent Vitamin B deficiency, which CAN INDICATE SEVERE COMPLICATIONS including failure in thriving, megaloblastic anemia, and development delays [3,14].']	[('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 230)]	5	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007567', 'parturition', 70, 'delivery'), ('CHEBI_33277', 'gamma-tocotrienol', 127, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 140, 'minerals'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin B')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3616124	4/2013	S174-PMC3616124	['daily Vitamin C and E did not prevent Preeclampsia or SERIOUS COMPLICATIONS of pah in low risk primiparous women of any hp phenotype.']	[('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 62)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 20, 'E'), ('GO_0007128', 'meiotic prophase I', 38, 'preeclampsia')]
PMC3629265	4/2013	S8-PMC3629265	["while these infants had several RISK FACTORS for Vitamin D deficiency, they were all receiving Cow's milk based formula supplemented with 400 iu/l of vitamin D.\n\nconclusion\nTHIS report SUGGESTS that CURRENT practice with regards to Vitamin D supplementation MAY BE INADEQUATE, especially for high-risk infants."]	[('SUPERFICIAL_RELATIONSHIP', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 173), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 199), ('INCOMPLETE_EVIDENCE', 258), ('IMPORTANT_CONSIDERATION', 265), ('PROBLEM_COMPLICATION', 265)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 95, 'cow'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3635901	4/2013	S38-PMC3635901	["[22], in their review, EMPHASIZED that patients AFFECTED with sjögren's syndrome (ss) who have low levels of Vitamin D are at a higher risk of developing SEVERE COMPLICATIONS such as lymphoma and peripheral neuropathy [23,24]."]	[('IMPORTANT_CONSIDERATION', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 154), ('PROBLEM_COMPLICATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3641012	4/2013	S76-PMC3641012	['this definition was used BECAUSE isolated values slightly above the upper limit of the reference range were not considered to be CONSISTENT with Vitamin D toxicity.']	[('PROBLEM_COMPLICATION', 25), ('INCOMPLETE_EVIDENCE', 129)]	2	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC3641012	4/2013	S252-PMC3641012	['as well, we DID NOT calculate total intake of Vitamin D DUE TO the LACK OF adequate information regarding Vitamin D content in the bangladeshi Food supply.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBLEM_COMPLICATION', 56), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 72)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33290', 'food', 143, 'food')]
PMC3773018	4/2013	S56-PMC3773018	['DUE TO SMALL sample size after stratification, the significant ASSOCIATION between persistently low Vitamin D and risk of fs was ONLY observed in children with 25(Oh)d measurements within 1 year of age (or=2.99, 95%ci: 1.05–8.52).']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 129)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 160, '25(OH)')]
PMC3773018	4/2013	S71-PMC3773018	['insufficient Vitamin D status is UNDESIRABLE from many viewpoints, ESPECIALLY BECAUSE of its IMPACT on bone health and Immune function.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 78), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]
PMC3773018	4/2013	S106-PMC3773018	['the extent of Vitamin D insufficiency in this process MAY BE UNDERESTIMATED by a static, single value, and emphasizes that longer term exposure to a Vitamin D deficient state MIGHT have profound health consequences in a specific Genetic environment.']	[('INCOMPLETE_EVIDENCE', 54), ('PROBLEM_COMPLICATION', 61), ('INCOMPLETE_EVIDENCE', 175)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('SO_0000704', 'gene', 229, 'genetic')]
PMC3651971	5/2013	S73-PMC3651971	['an unpaired, two-sided test statistic that accounted for clustering was calculated using the formula described by moulton and hayes36:where cpis the number of clusters in the Placebo group, cvathe number of clusters in the Vitamin A group,36and s can be calculated as the square-root of the variance, s2:where xijis the jth cluster mean of the i group, and xithe mean of all six of the i group clusters.36a ci for the difference in means was computed using the formula:where tv,0.025is the 2.5% of a t distribution with v=cpl\u2009+\u2009cva\u2009−\u20092 degrees of freedom.36\na two-step variation of this technique was used to estimate the treatment effect in an adjusted model that controlled for INFLUENCES of POTENTIAL CONFOUNDERS that were unevenly distributed between the two groups.']	[('SUPERFICIAL_RELATIONSHIP', 680), ('INCOMPLETE_EVIDENCE', 694), ('PROBLEM_COMPLICATION', 704)]	3	[('CHEBI_26130', 'biological pigment', 175, 'placebo'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin A')]
PMC3651971	5/2013	S139-PMC3651971	['the lack of EFFECT is UNLIKELY to be DUE TO a lack of Vitamin A deficiency among Pregnant women; ∼20% of mothers were NOTED to have a Serum Retinol concentration below 0.70\u2005µmol/l, a prevalence that fell to ∼3% with supplementation.20gestational night blindness of ∼10% also responded to Vitamin A supplementation,37and the risk of Maternal death was reduced by ∼40% through supplementation.20there was no lack of Cognitive or motor effect, which is LIKELY to be OWING TO the POOR response to supplementation among the offspring; infants Born to supplemented women had a higher Serum Retinol than infants Born to Placebo mothers by 3\u2005months of age.24the children Born to supplemented women also had better Lung function (as measured by the forced Expiratory volume at 1\u2005s and forced vital capacity)25and raised natural Antibody levels26in childhood, FURTHER EVIDENCE of a physiological EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 22), ('PROBLEM_COMPLICATION', 37), ('ANOMALY_CURIOUS_FINDING', 118), ('PROBABLE_UNDERSTANDING', 450), ('PROBLEM_COMPLICATION', 463), ('PROBLEM_COMPLICATION', 476), ('INCOMPLETE_EVIDENCE', 850), ('SUPERFICIAL_RELATIONSHIP', 886)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_26536', 'retinoic acid', 140, 'retinol'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin A'), ('GO_0007618', 'mating', 332, 'maternal'), ('GO_0050890', 'cognition', 414, 'cognitive'), ('GO_0007567', 'parturition', 538, 'born'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_26536', 'retinoic acid', 584, 'retinol'), ('GO_0007567', 'parturition', 605, 'born'), ('CHEBI_26130', 'biological pigment', 613, 'placebo'), ('GO_0007567', 'parturition', 663, 'born'), ('UBERON_0002048', 'lung', 706, 'lung'), ('GO_0010467', 'gene expression', 747, 'expiratory'), ('GO_0042571', 'immunoglobulin complex, circulating', 819, 'antibody')]
PMC3651971	5/2013	S151-PMC3651971	['ANOTHER POSSIBLE EXPLANATION for the LACK OF difference between groups is that unit and mabc are INSUFFICIENTLY PRECISE to pick up on subtle differences in Vitamin A nutriture.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 17), ('INCOMPLETE_EVIDENCE', 37), ('PROBLEM_COMPLICATION', 97)]	5	[('CHEBI_27300', 'vitamin D', 156, 'vitamin A')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3672018	5/2013	S12-PMC3672018	['THE PRESENT STUDY addresses these ISSUES in RELATION to Vitamin D.\n\nVitamin D\nvitamin D is a fat-soluble Vitamin that is NECESSARY for the Human body.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBLEM_COMPLICATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 68, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'D'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human')]
PMC3672018	5/2013	S29-PMC3672018	['with the high general prevalence of Vitamin D deficiency, the status of Pregnant and Lactating women is of particular CONCERN.']	[('PROBLEM_COMPLICATION', 118)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('GO_0007594', 'puparial adhesion', 85, 'lactating')]
PMC3672018	5/2013	S142-PMC3672018	['the comprehensive linkage of different datasets makes it possible to study the mediation, CONFOUNDING or modification of EFFECTS of Vitamin D for selected conditions through the development of sophisticated models in which Individuals can be followed for periods of up to 50\u2009years.']	[('PROBLEM_COMPLICATION', 90), ('SUPERFICIAL_RELATIONSHIP', 121)]	2	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('NCBITaxon_1', 'root', 223, 'individuals')]
PMC3672018	5/2013	S155-PMC3672018	['neither CONFOUNDING from external or internal factors, nor the LACK OF individual data on Vitamin D intake, is a prerequisite for the study, AS the INFLUENCES of lifestyle differences (e.g.']	[('PROBLEM_COMPLICATION', 8), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 141), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3705146	5/2013	S219-PMC3705146	['it is WELL KNOWN that a lack of Vitamin D causes rickets, which would have had a negative IMPACT the ability to perform the physical work NECESSARY to survive in historical times, BUT more IMPORTANTLY, frequently caused fatal outcomes during Delivery BECAUSE of the improper configuration of Pelvis in SEVERE rickets (harrison,1966; cruickshank,1967; konje and ladipo,2000).']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('PROBLEM_COMPLICATION', 251), ('IMPORTANT_CONSIDERATION', 302)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 242, 'delivery'), ('UBERON_0002355', 'pelvic region of trunk', 292, 'pelvis')]
PMC3717170	5/2013	S69-PMC3717170	["in addition, FEW randomized controlled trials HAVE BEEN conducted in Pregnant women to determine optimal Vitamin D status.13–15\ncarol l. wagner (medical university of south carolina) DISCUSSED two RECENT STUDIES performed by her group in collaboration with bruce hollis's group—the national institute of child health and Human development (nichd) Vitamin D Pregnancy trial12and the thrasher research fund Vitamin D community-based supplementation trial16—that INDICATE that 400 iu Vitamin D, the amount found in MOST Prenatal Vitamins, is INADEQUATE and that 4000 iu/day is NECESSARY to optimize 1,25(Oh)2D3Production, achieved when total circulating 25(Oh)d3is at least 40 ng/ml (fig."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 460), ('PROBABLE_UNDERSTANDING', 512), ('IMPORTANT_CONSIDERATION', 539), ('PROBLEM_COMPLICATION', 539), ('IMPORTANT_CONSIDERATION', 574)]	9	[('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 321, 'Human'), ('CHEBI_28384', 'vitamin K', 347, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 405, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 405, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 481, 'vitamin D'), ('GO_0007565', 'female pregnancy', 517, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 526, 'vitamins'), ('CHEBI_37983', 'sulfur-35 atom', 596, '1'), ('CHEBI_74151', 'S-palmitoyl-L-cysteine residue', 597, ',25(OH)2D3production'), ('PR_000029121', 'leucine-rich repeat and guanylate kinase domain-containing protein', 604, '2D3production'), ('CHEBI_33310', 'neon atom', 653, '(OH)')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC3717170	5/2013	S163-PMC3717170	['in large population-based studies, low levels of Vitamin D PREDICT loss of mobility and disability in Basic activities Of daily living, independent of age and other POTENTIAL CONFOUNDERS.47BASED on THESE FINDINGS, SOME gerontologists CLAIM that Vitamin D has antiaging EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 175), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 187), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 269)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'basic'), ('UBERON_0002828', 'ventral cochlear nucleus', 119, 'of'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3717170	5/2013	S187-PMC3717170	['there is GENERAL CONSENSUS that the earlier RECOMMENDATION of 400 iu of Vitamin D/day was INSUFFICIENT.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 90), ('PROBLEM_COMPLICATION', 90)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3679329	6/2013	S8-PMC3679329	['these results SUGGEST that among Pregnant and Lactating women, those who do not use dietary supplements TEND to have a lower intake of healthy Foods, such as beans and vegetables, as well as a lower intake of dietary fiber and Β-Carotene, which are abundant in these Foods, and non-users are more LIKELY than users to have INADEQUATE Intake of micro-Nutrient such as Vitamin C and iron.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 104), ('PROBABLE_UNDERSTANDING', 297), ('IMPORTANT_CONSIDERATION', 323), ('PROBLEM_COMPLICATION', 323)]	5	[('GO_0007565', 'female pregnancy', 33, 'pregnant'), ('GO_0007594', 'puparial adhesion', 46, 'lactating'), ('CHEBI_33290', 'food', 143, 'foods'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 227, 'β-carotene'), ('CHEBI_33290', 'food', 267, 'foods'), ('GO_0007631', 'feeding behavior', 334, 'intake'), ('CHEBI_33284', 'nutrient', 350, 'nutrient'), ('CHEBI_27300', 'vitamin D', 367, 'vitamin C')]
PMC3685533	6/2013	S10-PMC3685533	['conclusions\nthe PRESENT STUDY SHOWS a high prevalence of Vitamin D insufficiency and deficiency in newborns with significant differences observed to be DUE TO ethnicity, skin colour and maternal supplementation during the Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 152)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy')]
PMC3685533	6/2013	S124-PMC3685533	['after Birth ONLY fs newborns unsupplemented SHOWED Vitamin D levels higher than lob and mbb; no differences were found in case of maternal supplementation in Pregnancy, MOST LIKELY DUE TO a specific ROLE of supplementation in neonates.']	[('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 169), ('PROBABLE_UNDERSTANDING', 181), ('PROBLEM_COMPLICATION', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC3685533	6/2013	S136-PMC3685533	['conclusions\nthe PRESENT STUDY DEMONSTRATES a high prevalence of Vitamin D deficiency and insufficiency both in Cord Blood and in neonatal Serum with significant differences DUE TO ethnicity, skin colour and presence or absence of supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 173)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0009472', 'axilla', 111, 'cord blood'), ('UBERON_0001977', 'blood serum', 138, 'serum')]
PMC3691177	6/2013	S109-PMC3691177	['our results SUGGEST that the MOST LIKELY EXPLANATION for the FINDING of decreased wheezing risk in offspring of mothers with a higher Vitamin D intake during Pregnancy in observational studies[1]–[4], is CONFOUNDING by OTHER dietary or lifestyle factors ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 29), ('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 219), ('SUPERFICIAL_RELATIONSHIP', 254)]	8	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
PMC3702245	6/2013	S20-PMC3702245	['implications of low Vitamin D status during Pregnancy\n\nSkeletal and calcemic COMPLICATIONS\nit is GENERALLY ACCEPTED that maternal Vitamin D deficiency CAN result in osteomalacia.']	[('PROBLEM_COMPLICATION', 77), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 151)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('UBERON_0004288', 'skeleton', 55, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3702245	6/2013	S32-PMC3702245	['SEVERE hypocalcemia occasionally presenting as neonatal seizures is a known COMPLICATION of maternal Vitamin D deficiency during Pregnancy.66,67\n\nextraskeletal and noncalcemic COMPLICATIONS of Vitamin D deficiency during Pregnancy\nseveral Extraskeletal COMPLICATIONS of Vitamin D deficiency during Pregnancy HAVE BEEN REPORTED in the mother, fetus, and infant.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBLEM_COMPLICATION', 76), ('PROBLEM_COMPLICATION', 176), ('PROBLEM_COMPLICATION', 253), ('INCOMPLETE_EVIDENCE', 308)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 239, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnancy')]
PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]
PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3702245	6/2013	S63-PMC3702245	['a review of the FEW previous randomized controlled TRIALS of Vitamin D supplementation during Pregnancy INDICATES that doses of 400–1600 iu/day were INSUFFICIENT in achieving a mean Serum 25(Oh)D concentration ≥50 nmol/l in most of the studies.41in a RECENT Vitamin D supplementation TRIAL from the uk, a multiethnic group of 180 Pregnant women were randomized at 27 weeks’ Gestation to receive a single Oral dose of 200,000 iu of Vitamin D, daily supplementation of 800 iu, or no treatment.33the median Serum 25(Oh)D concentration in the 800 iu/day group at study entry was 26 nmol/l (interquartile range 22–37), and the median 25(Oh)D concentration at delivery following supplementation was 42 nmol/l (interquartile range 31–76).']	[('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 51), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 284)]	7	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 188, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnant'), ('GO_0007565', 'female pregnancy', 374, 'gestation'), ('UBERON_0000165', 'mouth', 404, 'oral'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D'), ('UBERON_0001977', 'blood serum', 504, 'serum'), ('CHEBI_71657', 'versiconol acetate', 510, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 510, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 629, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 629, '25(OH)D')]
PMC3702245	6/2013	S76-PMC3702245	['they HYPOTHESIZED that daily Vitamin D3Supplementation of 4000 iu/day would be more effective than 2000 iu and a standard dosing regimen of 400 iu in achieving a Serum 25(Oh)D concentration of >80 nmol/l without any safety ISSUES referable to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 223)]	3	[('CHEBI_52915', 'phosphatediyl group', 29, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 29, 'vitamin D3supplementation'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC3728489	7/2013	S317-PMC3728489	['NOTABLY, breastfed infants are at ESPECIALLY high RISK of Vitamin D deficiency DUE TO POOR penetrance of Vitamin D Metabolites in milk (kovacs,2013; thiele et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 50), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_25212', 'metabolite', 115, 'metabolites')]
PMC3798907	8/2013	S15-PMC3798907	['moreover, two of these cohorts have DEMONSTRATED that low maternal Vitamin E intake during Pregnancy is ASSOCIATED with increased in vitro proliferative responses by Cord Blood Mononuclear Cells (cbmc) and that this ASSOCIATION is independent of the POTENTIALLY CONFOUNDING EFFECTS of Birth order, sex, maternal atopy and maternal smoking [12,13].']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 250), ('PROBLEM_COMPLICATION', 262), ('SUPERFICIAL_RELATIONSHIP', 274)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CL_0000752', 'cone retinal bipolar cell', 166, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 166, 'cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('GO_0031097', 'medial cortex', 177, 'mononuclear'), ('GO_0007567', 'parturition', 285, 'birth')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC3798907	8/2013	S109-PMC3798907	['a further POSSIBILITY raised by THE CURRENT STUDY is that isolated maternal Vitamin E supplementation during Pregnancy MAY have MIXED or EVEN adverse CONSEQUENCES for atopic sensitisation to different Allergens.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ANOMALY_CURIOUS_FINDING', 137), ('PROBLEM_COMPLICATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_33663', 'cyclic hydrocarbon', 201, 'allergens')]
PMC3798907	8/2013	S110-PMC3798907	['this CONCERN is SUPPORTED by the RECENT report that high-dose Antenatal Vitamin C and E supplementation is ASSOCIATED with increased infant healthcare utilisation and cost of care [23].']	[('IMPORTANT_CONSIDERATION', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 107)]	5	[('GO_0007567', 'parturition', 62, 'antenatal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC3798907	8/2013	S136-PMC3798907	['the original ASSOCIATION between maternal Vitamin E and cbmc responses was INDEPENDENT of many POTENTIALLY CONFOUNDING FACTORS (Birth order, maternal atopy, maternal smoking, sex [12], and maternal bmi [27], MAKING IT UNLIKELY that any EFFECT of in vitro Vitamin E supplementation was being negated by extraneous factors, moreover the EFFECT of supplementation was compared with an unsupplemented control for each subject.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 75), ('INCOMPLETE_EVIDENCE', 95), ('PROBLEM_COMPLICATION', 107), ('PROBABLE_UNDERSTANDING', 208), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 335)]	8	[('CHEBI_27300', 'vitamin D', 42, 'vitamin E'), ('GO_0007567', 'parturition', 128, 'birth'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin E')]
PMC3760821	9/2013	S108-PMC3760821	['the results in this table have not been analysed with respect to season and observed differences in t1dm and control women are, THEREFORE, DUE TO differences in season of sampling.10.1371/journal.pone.0074068.t002\n\ncaption (table-wrap): table 2\nVitamin D deficiency and insufficiency of Pregnant women and neonates, split by maternal diabetes, using various cut-off levels.Pregnant womengestation and level of Vitamin D deficiencycontrol groupt1dm groupn%n%≤14 weeks<12.5 nmol/l14.511.8<25 nmol/l1045.5916.4<50 nmol/l1672.74174.5<75 nmol/l2090.95090.9<100 nmol/l22100.05498.2>14<28 weeks<12.5 nmol/l25.011.5<25 nmol/l2152.51929.2<50 nmol/l3485.04670.8<75 nmol/l3997.56193.8<100 nmol/l40100.065100.0≥28 weeks<12.5 nmol/l611.534.8<25 nmol/l2650.02845.2<50 nmol/l4586.55182.3<75 nmol/l5198.162100.0<100 nmol/l52100.062100.0 Pregnant womenneonatal level of Vitamin D deficiencycontrol groupt1dm groupn%n% Cord Blood<12.5 nmol/l832.01628.6<25 nmol/l2392.04478.6<50 nmol/l25100.056100.0\ndata are cumulative n and cumulative %.']	[('PROBABLE_UNDERSTANDING', 128), ('PROBLEM_COMPLICATION', 139)]	2	[('CHEBI_28384', 'vitamin K', 245, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 245, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 287, 'pregnant'), ('GO_0007565', 'female pregnancy', 373, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin D'), ('GO_0007565', 'female pregnancy', 821, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 853, 'vitamin D'), ('UBERON_0000948', 'heart', 901, 'Cord'), ('UBERON_0000178', 'blood', 906, 'blood')]
PMC3814422	10/2013	S15-PMC3814422	['HENCE, the value of analysing dietary Vitamin D intake alone AS a means of EFFECTIVELY establishing the INFLUENCE of Vitamin D on outcomes HAS BEEN QUESTIONED as it leads to considerable MISCLASSIFICATION of total exposure.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('PROBLEM_COMPLICATION', 187)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3814422	10/2013	S20-PMC3814422	['factors such as residual CONFOUNDING, chance results attributable to SMALL sample sizes and differences in HOW Vitamin D exposure and childhood outcomes were measured (i.e.']	[('PROBLEM_COMPLICATION', 25), ('INCOMPLETE_EVIDENCE', 69), ('EXPLICIT_QUESTION', 107)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3814422	10/2013	S47-PMC3814422	['potential confounders and mediators\nwe considered the following as POTENTIAL CONFOUNDERS BECAUSE of their KNOWN or POTENTIAL PLAUSIBLE ASSOCIATION with both maternal concentrations of Vitamin D and with childhood atopic and Lung function outcomes21,22: maternal FACTORS during Pregnancy [smoking, infections, anxiety score, Antibiotic use, Paracetamol use, body mass index (bmi) and Alcohol intake], OTHER maternal factors (educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine) and Postnatal FACTORS that MAY reflect a background socio-economic CONFOUNDING pathway originating prior to Birth (breastfeeding, day care, pets, exposure to damp/mould in home, environmental tobacco smoke exposure and number of younger siblings).']	[('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('PROBLEM_COMPLICATION', 89), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 135), ('SUPERFICIAL_RELATIONSHIP', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 400), ('SUPERFICIAL_RELATIONSHIP', 579), ('INCOMPLETE_EVIDENCE', 592), ('PROBLEM_COMPLICATION', 632)]	12	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0002048', 'lung', 224, 'lung'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 324, 'antibiotic'), ('CHEBI_46195', 'paracetamol', 340, 'paracetamol'), ('CHEBI_30879', 'alcohol', 383, 'alcohol'), ('GO_0007567', 'parturition', 569, 'postnatal'), ('GO_0007567', 'parturition', 673, 'birth')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC3827489	10/2013	S29-PMC3827489	['prevalence of Vitamin D insufficiency or deficiency\nepidemiologic data on the prevalence of Vitamin D insufficiency or deficiency in children are SPARSE or INCOMPLETE in most countries.']	[('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 156), ('PROBLEM_COMPLICATION', 156)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3827489	10/2013	S100-PMC3827489	['it is NOT KNOWN, however, HOW much amount of Vitamin D supplementation is NEEDED for korean children and Pregnant women in order to maintain adequate concentrations of vitamin D. CONSIDERING the high prevalence of Vitamin D insufficiency or deficiency in koreans, ESPECIALLY children and adolscents6,22-24), this ISSUE NEEDS TO BE addressed URGENTLY by FUTURE STUDIES.']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 26), ('IMPORTANT_CONSIDERATION', 74), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 264), ('PROBLEM_COMPLICATION', 313), ('IMPORTANT_CONSIDERATION', 319), ('IMPORTANT_CONSIDERATION', 341), ('FUTURE_WORK', 353)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4231606	10/2013	S122-PMC4231606	['regression techniques were employed to determine WHETHER the ASSOCIATION between caries and Vitamin D status REMAINED after controlling for CONFOUNDERS.']	[('EXPLICIT_QUESTION', 49), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 140)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3991049	11/2013	S19-PMC3991049	['Vitamin D receptors can be found in most Tissues and cells in the body, and the IMPACT of a Vitamin D deficiency on the developing fetus and maternal health is of significant CONCERN.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 175)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 41, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3991049	11/2013	S70-PMC3991049	['all of this SUPPORTS that 400 iu of Vitamin D MAY BE INADEQUATE to raise the maternal Vitamin D level to optimum level PARTICULARLY for women living in northern latitude, women with darker skin or covered women, as well as for women who are not exposed to sunlight, not on dietary supplements or have absorption and metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 53), ('PROBLEM_COMPLICATION', 53), ('ANOMALY_CURIOUS_FINDING', 119), ('PROBLEM_COMPLICATION', 326)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3991049	11/2013	S71-PMC3991049	['we used a 50,000 iu dose, AS per our PREVIOUS STUDIES, which DEMONSTRATED no toxicity when Vitamin D deficient rheumatology outpatient and health care professional were supplemented this dose.31–32\nthe CONCERN of using higher doses of Vitamin D MIGHT cause hypercalcemia, hypercalciuria, Renal calculi and soft Tissue and vascular calcification toxicity is LIKELY to worsen with Calcium supplementation.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 202), ('PROBLEM_COMPLICATION', 202), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 357)]	7	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0002113', 'kidney', 288, 'renal'), ('UBERON_0000479', 'tissue', 311, 'tissue'), ('CHEBI_22313', 'alkaline earth metal atom', 379, 'calcium')]
PMC3991049	11/2013	S80-PMC3991049	['we NEED rct of Vitamin D supplementation with measurement of 25-Hydroxyvitamin D to determine the baseline status, the level achieved on supplementation with appropriate design to avoid any CONFOUNDER, and TO ASSESS WHAT is the appropriate level of Vitamin D during Pregnancy and in newborns with no complications or toxicity through out.']	[('FUTURE_WORK', 3), ('PROBLEM_COMPLICATION', 190), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('EXPLICIT_QUESTION', 216)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 61, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC3873449	12/2013	S53-PMC3873449	['Vitamin D intake in Food was not collected SINCE usually little Food in chinese diet contains reasonable amounts of Vitamin D. it should be NOTED that in china, dairy Products are not fortified with Vitamin D. the questionnaire also SOUGHT information about behavioral factors like daily duration of computer use and daily duration of sun exposure (duration-number of hours per day).']	[('PROBLEM_COMPLICATION', 43), ('ANOMALY_CURIOUS_FINDING', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 233)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_33290', 'food', 20, 'food'), ('CHEBI_33290', 'food', 64, 'food'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_38873', 'prothiofos', 167, 'products'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
PMC3873449	12/2013	S123-PMC3873449	['direct comparisons between studies are not possible DUE TO the use of DIFFERENT methods and INCONSISTENT definitions of Vitamin D deficiency.']	[('PROBLEM_COMPLICATION', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3873449	12/2013	S167-PMC3873449	['women in beijing can not produce enough Vitamin D through sunshine exposure in winter DUE TO multiple FACTORS.']	[('PROBABLE_UNDERSTANDING', 86), ('PROBLEM_COMPLICATION', 86), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3873449	12/2013	S188-PMC3873449	['HOWEVER, SINCE there is INSUFFICIENT DATA to evaluate the EFFECTIVENESS of Vitamin D supplementation during Pregnancy Vitamin D supplementation as routine Antenatal care is YET TO BE DETERMINED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 58), ('FULL_UNKNOWN', 173)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 155, 'antenatal')]
PMC3882256	1/2014	S108-PMC3882256	['there was also no association between cord ferritin and either maternal dietary iron intake or hemoglobin.10.1371/journal.pone.0084684.t005\n\ncaption (table-wrap): table 5\nmultivariable linear regression estimates from stratified analyses for associations between Maternal Iron intake and hemoglobin in Pregnancy with offspring vascular indicators and body mass index with testing for EFFECT modification by maternal Vitamin C intake during Pregnancy and child sex (n\u200a=\u200a2958).offspring pulse wavevelocity (m/s)offspring Flow mediateddilatation (%)offspring systolic bloodpressure (mmhg)offspring diastolic bloodpressure (mmhg)offspring body massindex (kg/m2)b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p* Maternal Pregnancy dietary iron intake (continuous) (per 10 mg/d) in participants with Vitamin Cintake >50 mg/day0−0.3, 0.30.50.6−0.2, 1.50.5−0.3−2.4, 1.90.70.8−1.1, 2.70.80−.0.7, 0.60.3in participants with Vitamin Cintake ≤50 mg/day0.2−0.7, 1.1−0.3−2.7, 2.1−1.8−7.3, 3.71.2−4.0, 6.41.2−1.1, 3.5males0.2−0.2, 0.60.40.6−0.4, 1.60.20.4−2.3, 3.10.90.9−1.5, 3.20.70.2−0.7, 1.00.4females0−0.4, 0.40.5−0.7, 1.6−0.9−3.8, 2.00.7−1.9, 3.30.1−0.9, 1.0 maternal Pregnancy Iron supplement use in participants with Vitamin cintake >50 mg/day0−0.1, 0.20.20.30, 0.70.1−0.8−1.7, 0.10.9−0.4−1.2, 0.50.90.1−0.2, 0.30.9in participants with Vitamin Cintake ≤50 mg/day0.2−0.1, 0.5−0.3−1.1, 0.6−0.8−2.7, 1.2−0.1−2.0, 1.80−0.8, 0.8males0.1−0.1, 0.20.80.2−0.2, 0.60.9−0.9−2.1, 0.30.7−0.9−1.9, 0.10.06−0.1−0.4, 0.30.5females0.1−0.1, 0.20.3−0.3, 0.7−0.7−1.9, 0.50.2−0.8, 1.30.1−0.3, 0.5 maternal early Pregnancy anemia (<11 g/dl) males0−0.4, 0.40.90.2−0.9, 1.20.3−1.3−4.1, 1.40.80.3−2.1, 2.60.40.4−0.5, 1.20.2females−0.1−0.5, 0.4−0.5−1.7, 0.7−1.0−4.1, 2.1−0.9−3.7, 1.8−0.2−1.2, 0.8\n#adjusting for potential CONFOUNDING characteristics: maternal age, pre-Pregnancy bmi, smoking in Pregnancy, educational qualification (AS a PROXY for socioeconomic status), parity, and maternal total energy intake in the models with dietary iron intake as exposure).']	[('SUPERFICIAL_RELATIONSHIP', 384), ('PROBLEM_COMPLICATION', 1794), ('PROBABLE_UNDERSTANDING', 1905), ('SUPERFICIAL_RELATIONSHIP', 1910)]	4	[('GO_0007618', 'mating', 263, 'maternal'), ('CHEBI_24870', 'ion', 272, 'iron'), ('GO_0007565', 'female pregnancy', 302, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 416, 'vitamin C'), ('GO_0007565', 'female pregnancy', 440, 'pregnancy'), ('GO_0007601', 'visual perception', 519, 'flow'), ('GO_0007618', 'mating', 713, 'Maternal'), ('GO_0007565', 'female pregnancy', 722, 'pregnancy'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 800, 'vitamin Cintake'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 920, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1164, 'pregnancy'), ('CHEBI_24870', 'ion', 1174, 'iron'), ('CHEBI_33229', 'vitamin (role)', 1215, 'vitamin'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 1334, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1589, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1841, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1867, 'pregnancy')]
PMC4071151	6/2014	S64-PMC4071151	['RISK factors MAY include preoperative malnutrition (e.g., Vitamin D, iron), decreased Food Intake (dumping syndrome, reduced hunger and increased satiety, Food intolerances), inadequate Nutrient supplementation (POOR compliance with multivitamin/multimineral regimen, insufficient amounts of Vitamins and/or Minerals in supplements) and/or nutritional support (lack of follow-up, INSUFFICIENT monitoring, DIFFICULTY in recognizing symptoms of deficiency), Nutrient malabsorption (reduced absorptive Gastro-Intestinal area) [18,19].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 212), ('PROBLEM_COMPLICATION', 380), ('DIFFICULT_TASK', 405)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 86, 'food'), ('GO_0007631', 'feeding behavior', 86, 'food intake'), ('CHEBI_33290', 'food', 155, 'food'), ('CHEBI_33284', 'nutrient', 186, 'nutrient'), ('CHEBI_33277', 'gamma-tocotrienol', 292, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 308, 'minerals'), ('CHEBI_33284', 'nutrient', 456, 'nutrient'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 499, 'gastro-intestinal')]
PMC4072587	6/2014	S155-PMC4072587	['conclusions\nOUR STUDY INDICATES that low levels of Vitamin D during Pregnancy are of CONCERN in rural vietnam, and are ASSOCIATED with impaired Language Development at 6 months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('PROBLEM_COMPLICATION', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 144, 'language development')]
PMC4113768	7/2014	S356-PMC4113768	['DUE TO the unavailability of subsidized daily doses of Vitamin D and the unaffordability of Vitamin D testing in new zealand we have established a less than IDEAL process for treating and PREVENTING Vitamin D deficiency in our IDENTIFIED high risk women and children, using monthly doses of 50,000 iu Cal-D forte for women and Vitadol-c (multivitamin) for breast feeding babies.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 157), ('SUPERFICIAL_RELATIONSHIP', 188), ('INCOMPLETE_EVIDENCE', 227)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_17789', 'dihydrochelirubine', 301, 'Cal-D'), ('PR_000004968', 'calretinin', 301, 'Cal-D'), ('CHEBI_27355', 'xylulose phosphate', 327, 'vitadol')]
PMC4113768	7/2014	S466-PMC4113768	['2 large randomized controlled trials (rcts) of Vitamin A have HAD TO BE stopped DUE TO an increased incidence of Lung cancer and in Cardiac deaths.']	[('IMPORTANT_CONSIDERATION', 62), ('PROBLEM_COMPLICATION', 80)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('UBERON_0002048', 'lung', 113, 'lung'), ('UBERON_0000948', 'heart', 132, 'cardiac')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]
PMC4113768	7/2014	S852-PMC4113768	['most data regarding the EFFECTS of Vitamin D on non-Skeletal Tissues in young People HAS BEEN obtained from cross-sectional studies, with their ASSOCIATED LIMITATIONS.we have THEREFORE UNDERTAKEN a systematic review of randomised controlled trials (rcts) that has EXAMINED the IMPACT of Vitamin D on muscle strength and function in young People.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 144), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 155), ('PROBABLE_UNDERSTANDING', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 264), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0004288', 'skeleton', 52, 'skeletal'), ('UBERON_0000479', 'tissue', 61, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'people'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 338, 'people')]
PMC4113768	7/2014	S1084-PMC4113768	['background: reports SUGGEST that Vitamin D deficiency (vdd), and its clinical COMPLICATIONS, have increased in prevalence among children in the uk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 78), ('PROBLEM_COMPLICATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4113768	7/2014	S1439-PMC4113768	['this is of CONCERN SINCE it MAY REFLECT undiagnosed levels of Vitamin D deficiency/insufficiency in the wider population.']	[('PROBLEM_COMPLICATION', 11), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 32)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S1840-PMC4113768	['this is of particular IMPORTANCE DUE TO the seasonal DEPENDENCE on dietary sources of Vitamin D in denmark.']	[('IMPORTANT_CONSIDERATION', 22), ('PROBLEM_COMPLICATION', 33), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S1866-PMC4113768	['; lanham-new, s.\nbackground: maintaining a healthy Vitamin D status is PROBLEMATIC within the uk, largely DUE TO a combination of two FACTORS: required uv exposure for dermal Production Of Vitamin D is limited by seasonality and there are few Vitamin D-rich foods readily available within the diet.']	[('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 175, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4113768	7/2014	S2104-PMC4113768	['conclusions: low Vitamin D levels were ASSOCIATED with an INCREASED RISK of stroke in this prospective cohort study of older primary care patients.this ASSOCIATION was INDEPENDENT of several IMPORTANT CONFOUNDERS and ONLY PARTLY EXPLAINED by conventional risk factors and Cardiovascular disease AS POTENTIAL causal intermediates.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 191), ('PROBLEM_COMPLICATION', 201), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('PROBABLE_UNDERSTANDING', 295), ('INCOMPLETE_EVIDENCE', 298)]	11	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 272, 'cardiovascular')]
PMC4113768	7/2014	S2499-PMC4113768	['female ballet dancers and gymnasts are known to have POOR Vitamin D status POSSIBLY DUE TO heavy indoor training schedules limiting sun exposure, however it is LIKELY that their high levels of physical activity ameliorate the DETRIMENTAL EFFECTS of low Vitamin D and dietary Calcium.']	[('IMPORTANT_CONSIDERATION', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 160), ('IMPORTANT_CONSIDERATION', 226), ('SUPERFICIAL_RELATIONSHIP', 238)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 275, 'calcium')]
PMC4113768	7/2014	S2547-PMC4113768	['we applied gee regression methods to quantify the ASSOCIATIONS of Vitamin D supplementation and 25(Oh)D with Serum Calcium, while considering the CONFOUNDING POTENTIAL of age, gender, and body weight status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('PROBLEM_COMPLICATION', 146), ('INCOMPLETE_EVIDENCE', 158)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0001977', 'blood serum', 109, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 115, 'calcium')]
PMC4113768	7/2014	S2673-PMC4113768	['the isolated decrease in systolic bp among the Vitamin D group at 5-months follow-up is MOST LIKELY a chance FINDING, SINCE this small difference was not observed at 18-months.']	[('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 109), ('PROBABLE_UNDERSTANDING', 118), ('PROBLEM_COMPLICATION', 118)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4113768	7/2014	S2725-PMC4113768	['OF CONCERN is that People taking 10,000 iu/day or less are SHOWING high to toxic levels of 25Ohd, ALTHOUGH we do NOT KNOW HOW many, if any, of these users are displaying signs of Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 3), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 98), ('FULL_UNKNOWN', 113), ('EXPLICIT_QUESTION', 122)]	6	[('NCBITaxon_10088', 'Mus <genus>', 19, 'people'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 91, '25OHD'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4113768	7/2014	S2820-PMC4113768	['methods: a total of 49 apparently healthy Adults ( n = 23 males; n = 26 female) aged 18–65 years consented to take part in the current study, conducted between february and march 2013 to remove the CONFOUNDING EFFECT of sun exposure on circulating MARKERS of Vitamin D status.']	[('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 248)]	3	[('UBERON_0007023', 'adult organism', 42, 'adults'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4113768	7/2014	S3303-PMC4113768	['HOWEVER, rcts in iran, where the mean Serum 25(Oh)D levels TEND to be low, IN PART DUE TO sun avoidance during the hot summers, have FOUND beneficial EFFECTS of Vitamin D supplementation on cvd RISK FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 83), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('SUPERFICIAL_RELATIONSHIP', 194)]	7	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 44, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4142706	7/2014	S72-PMC4142706	['this FINDING made it IMPOSSIBLE to carry out this test SINCE Vitamin C was present in cell extracts and masked the results (azqueta et al., 2009,2013b).']	[('INCOMPLETE_EVIDENCE', 5), ('DIFFICULT_TASK', 21), ('PROBLEM_COMPLICATION', 55)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C')]
PMC4645901	8/2014	S52-PMC4645901	['see supplementary file: ds2663.doc - “tables and figures”\n\ndesign\nfollowing discussions with the parents and the clinical team, we RECOGNISED that there was a LACK OF AWARENESS of the IMPORTANCE of Vitamin D for the health and Development Of Babies.']	[('PROBABLE_UNDERSTANDING', 131), ('PROBLEM_COMPLICATION', 159), ('IMPORTANT_CONSIDERATION', 167), ('IMPORTANT_CONSIDERATION', 184)]	4	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0048513', 'animal organ development', 227, 'development of babies')]
PMC4169453	9/2014	S20-PMC4169453	['the RECOMMENDED Vitamin D intake VARIES from 400 iu/d to 2000 iu/d[7],[12]–[16], BUT supplementation using less than 1000 iu/d MAY BE INADEQUATE for maintaining an “optimal” 25(Oh)D level[17].']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 134), ('PROBLEM_COMPLICATION', 134)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D')]
PMC4169453	9/2014	S183-PMC4169453	['in CONSEQUENCE, fundamental QUESTIONS of: a) HOW much Vitamin D is enough to reach and maintain OPTIMAL 25(Oh)D level, and b) what is the OPTIMAL range for 25(Oh)D levels, REMAIN an ISSUE of DEBATE[32],[33].']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 138), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	8	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 106, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC4380518	9/2014	S6-PMC4380518	['conclusions\nongoing trials of Vitamin D supplementation during Pregnancy SHOULD CONSIDER POTENTIAL EFFECT MODIFICATION by race/ethnicity.']	[('FUTURE_WORK', 73), ('FUTURE_WORK', 80), ('INCOMPLETE_EVIDENCE', 89), ('PROBLEM_COMPLICATION', 99)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S52-PMC4380518	['shea et al studied 2500 elderly Adults and FOUND that lack of pnv use was ASSOCIATED with higher odds of Vitamin D insufficiency (<75 nmol/l) in both black (5.2 (95% ci: 3.5, 7.7)) and white participants (or 2.6, 95% ci: 2.0, 3.2), HOWEVER these subjects were much older and not Pregnant.26a SMALL turkish STUDY of 79 Pregnant women SHOWED significantly higher 25(Oh)D levels among women reporting pnv use in the third trimester,27BUT this study DID NOT include women of african descent and DID NOT have the power to address POTENTIAL INTERACTION by bmi.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 333), ('PROBLEM_COMPLICATION', 431), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 491), ('INCOMPLETE_EVIDENCE', 525), ('SUPERFICIAL_RELATIONSHIP', 535)]	10	[('UBERON_0007023', 'adult organism', 32, 'adults'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnant'), ('GO_0007565', 'female pregnancy', 318, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 361, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 361, '25(OH)D')]
PMC4380518	9/2014	S69-PMC4380518	['ONGOING TRIALS of Vitamin D supplementation during Pregnancy SHOULD CONSIDER EFFECT MODIFICATION by race/ethnicity.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 61), ('FUTURE_WORK', 68), ('PROBLEM_COMPLICATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC4329745	10/2014	S95-PMC4329745	['THIS STUDY was performed on Vitamin D status specially on women .we did have some LIMITATIONS in our work; detailed diet habits of the participants as well as rates of sun exposure were NOT CONSIDERED in the method BECAUSE of practical DIFFICULTIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 215), ('DIFFICULT_TASK', 236)]	5	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5685050	10/2014	S43-PMC5685050	['thai women are at risk for Vitamin D insufficiency LIKELY DUE TO sunscreen usage and sun avoidant behavior DUE TO the desire to maintain a fair complexion.']	[('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 58), ('PROBLEM_COMPLICATION', 107)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5685050	10/2014	S44-PMC5685050	['living in urban areas such as in bangkok, increases the risk of Vitamin D insufficiency DUE TO increased pollution, which decreases the amount of uvb available for cutaneous Vitamin D Synthesis.']	[('PROBLEM_COMPLICATION', 88)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 174, 'vitamin D synthesis')]
PMC5685050	10/2014	S48-PMC5685050	['in summary, DESPITE a location near the equator where sunlight is available year round, thai People are at risk for Vitamin D insufficiency DUE TO environmental, cultural, lifestyle and dietary factors.']	[('ANOMALY_CURIOUS_FINDING', 12), ('PROBLEM_COMPLICATION', 140)]	2	[('NCBITaxon_10088', 'Mus <genus>', 93, 'people'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4221707	11/2014	S20-PMC4221707	['SIMILAR STUDIES focusing on early Pregnant caucasian women in great britain HAVE SHOWN INADEQUATE intakes of Vitamin C, Folate, Calcium, and iron [8–10].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 76), ('PROBLEM_COMPLICATION', 87)]	3	[('GO_0007565', 'female pregnancy', 34, 'pregnant'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 120, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 128, 'calcium')]
PMC4221707	11/2014	S24-PMC4221707	['THUS, the low intake of Folate, Vitamin D, and iron FOUND in swedish women who are of Childbearing age is of SPECIAL CONCERN, as women do not SEEM to improve the quality of their overall diet during Pregnancy [7,15].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 109), ('PROBLEM_COMPLICATION', 117), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_30863', '5-azaorotic acid', 24, 'folate'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 86, 'childbearing'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4221707	11/2014	S204-PMC4221707	['the low intake of Folate, Vitamin D, and iron from Food are of SPECIAL CONCERN.']	[('ANOMALY_CURIOUS_FINDING', 63), ('PROBLEM_COMPLICATION', 71)]	2	[('CHEBI_30863', '5-azaorotic acid', 18, 'folate'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_33290', 'food', 51, 'food')]
PMC4251419	12/2014	S138-PMC4251419	['the LACK OF any PROTECTIVE EFFECT of Vitamin D supplementation in Adulthood MAY BE BECAUSE the processes necessary for disease have already been put in place much earlier in life.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 83), ('PROBLEM_COMPLICATION', 83)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 66, 'adulthood')]
PMC4256222	12/2014	S99-PMC4256222	['adjustment for Vitamin D status did not attenuate this ASSOCIATION as would be expected if the ASSOCIATION were DUE TO seasonal variation in Vitamin D status, RATHER it was strengthened upon adjustment.']	[('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBLEM_COMPLICATION', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4256222	12/2014	S140-PMC4256222	['in this context, a POTENTIAL negative IMPACT of maternal Vitamin D deficiency MAY have been BLURRED in our data, SINCE data are lacking on POTENTIALLY IMPORTANT CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 113), ('PROBLEM_COMPLICATION', 113), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 151), ('PROBLEM_COMPLICATION', 161)]	9	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4256222	12/2014	S142-PMC4256222	['IF this also is the case in the dafo88 cohort, physical activity level and childhood Vitamin D intake COULD did NOT act as CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 112), ('PROBLEM_COMPLICATION', 123)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4289064	1/2015	S165-PMC4289064	['the wide DIFFERENCES we find among populations for Vitamin A (table 2) SUGGEST that global data on crop and Nutrient Production (e.g.,[10]) are INSUFFICIENT for predicting the EFFECTS of pollinator declines on Human health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 71), ('PROBLEM_COMPLICATION', 144), ('SUPERFICIAL_RELATIONSHIP', 176)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('CHEBI_33284', 'nutrient', 108, 'nutrient'), ('GO_0007128', 'meiotic prophase I', 117, 'production'), ('NCBITaxon_9606', 'Homo sapiens', 210, 'human')]
PMC4302429	1/2015	S89-PMC4302429	['at 24\xa0hours after infection, Vitamin D-deficient Mice had a TENDENCY towards a greater weight loss ( p \u2009=\u20090.22; figure\xa01b), the difference failing to reach statistical significance BECAUSE of high interindividual variation.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('PROBLEM_COMPLICATION', 181)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 49, 'mice')]
PMC4396835	1/2015	S71-PMC4396835	['DUE TO the WELL-KNOWN ethnic disparity of Vitamin D status, we chose to categorise the participants into three ethnic origin groups: swedish, miscellaneous (non-scandinavian europe, south america and east asia) and african/middle east.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 11)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4396835	1/2015	S136-PMC4396835	['PREVIOUS FINDINGS of low levels of Vitamin D COULD REFLECT the CONSEQUENCES of asd per se, that is, the IMPACT of a Person’s indoor lifestyle and circumscribed diet.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBLEM_COMPLICATION', 63), ('SUPERFICIAL_RELATIONSHIP', 104)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'person')]
PMC4476607	1/2015	S147-PMC4476607	['ALTHOUGH antioxidant treatments in Animal MODELS are encouraging, researchers PREMATURELY terminated a clinical trial utilizing high doses of Vitamins C and E in women with Alcohol-exposed Pregnancies BECAUSE of SAFETY CONCERNS (goh et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 42), ('PROBLEM_COMPLICATION', 78), ('PROBLEM_COMPLICATION', 201), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 219), ('PROBLEM_COMPLICATION', 219)]	9	[('NCBITaxon_33208', 'Metazoa', 35, 'animal'), ('CHEBI_27300', 'vitamin D', 142, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 157, 'E'), ('CHEBI_30879', 'alcohol', 173, 'alcohol'), ('GO_0007565', 'female pregnancy', 189, 'pregnancies')]
PMC4383226	2/2015	S42-PMC4383226	['ON THE OTHER HAND, CONCERN HAS BEEN RAISED by an APPARENT increase in levels of parasitemia within Mouse MODELS, when combining Vitamin A supplements with dtp vaccination; an EFFECT THOUGHT TO be stronger among female Mice (jorgensen et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 27), ('EXPLICIT_QUESTION', 36), ('ANOMALY_CURIOUS_FINDING', 49), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 175), ('INCOMPLETE_EVIDENCE', 182)]	8	[('NCBITaxon_10088', 'Mus <genus>', 99, 'mouse'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice')]
PMC4383226	2/2015	S131-PMC4383226	['moreover, BECAUSE of the observational nature of our study design, high-quality randomized clinical TRIALS ARE NEEDED to confirm the efficacy of Vitamin A in preventing malaria, PARTICULARLY among children exposed to Placental malaria.']	[('PROBLEM_COMPLICATION', 10), ('FUTURE_WORK', 100), ('ANOMALY_CURIOUS_FINDING', 178)]	3	[('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('UBERON_0001987', 'placenta', 217, 'placental')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4377870	3/2015	S139-PMC4377870	['WHILE Vitamin D has beneficial EFFECTS INDEPENDENT of uv exposure [109], it can be DIFFICULT to separate this POTENTIAL CONFOUNDER from direct EFFECTS of Vitamin D on Lung health [110].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 39), ('DIFFICULT_TASK', 83), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 120), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4392531	3/2015	S89-PMC4392531	['HOWEVER, DUE TO the high amount of Vitamin A and e to protect Fatty Acids, the POSSIBILITY of hypervitaminosis SHOULD BE taken into account.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 111)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acids')]
PMC4405493	4/2015	S20-PMC4405493	['RECENT observational and randomized control trials have ATTEMPTED TO investigate THIS ISSUE, but there REMAINS LIMITED GUIDANCE on the management of Vitamin D deficiency during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 56), ('INCOMPLETE_EVIDENCE', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_WORK', 119)]	9	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC4405493	4/2015	S105-PMC4405493	['BECAUSE there were TOO few patient in the category of Vitamin D deficient (<20ng/ml [50nmol/l]) for meaningful statistical analysis, patients categorized as either Vitamin D insufficient or deficient were combined into one category (insufficient/deficient, <30ng/ml [75nmol/l]) for subsequent statistical analysis (table 5).10.1371/journal.pone.0123763.t004\n\ncaption (table-wrap): table 4\ndistribution of clinical outcomes in women categorized as Vitamin D deficient, insufficient, or sufficient.Vitamin D categoryno complications n (% of 176)all complications n (% of 59)Preeclampsia n (% of 19)spontaneous Preterm Delivery n (% of 10)iugr n (% of 9)gdm n (% of 5)spontaneous fetal loss n (% of 16) deficient (<20 ng/ml) 18 (10)6 (10)2 (11)1 (10)1 (11)0 (0)2 (13) (n = 24)insufficient (21–29 ng/ml) 105 (60)36 (61)10 (53)6 (60)7 (78)3 (60)10 (63) (n = 141)sufficient (>30 ng/ml) 53 (30)17 (29)7 (37)3 (30)1 (11)2 (40)4 (25) (n = 70)\niugr, Intrauterine growth restriction; gdm, Gestational diabetes mellitus.10.1371/journal.pone.0123763.t005\n\ncaption (table-wrap): table 5\nlogistic regression analysis of clinical outcomes in women categorized as Vitamin D sufficient compared to Vitamin D insufficient or deficient women.Vitamin D sufficient (≥30 ng/ml)Vitamin D insufficient or deficient (<30 ng/ml)n (% of 70)n (% of 165)adjusted**or (95% ci)* no complications 53 (75.7)123 (74.5)- all complications 17 (24.2)42 (25.5)1.01 (0.947–1.164) Preeclampsia 7 (10)12 (7.2)1.36 (0.48–3.88) spontaneous Preterm Delivery 3 (4.3)7 (4.2)0.78 (0.17–3.55) iugr 1 (1.4)8 (4.8)0.33 (0.38–2.83) gdm 2 (2.9)3 (1.8)2.60 (0.28–27.24) spontaneous abortion 4 (5.7)12 (7.2)0.65 (0.18–2.28)\n*, note: none of the differences were p<0.05 by logistic regression (chi-square analysis)\n**, adjusted for bmi, season, ethnicity, and tobacco use\nor, odds ratio\niugr, Intrauterine growth restriction; gdm, Gestational diabetes mellitus.']	[('PROBLEM_COMPLICATION', 0), ('PROBLEM_COMPLICATION', 19)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 447, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 447, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 496, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 496, 'Vitamin D'), ('GO_0007128', 'meiotic prophase I', 572, 'Preeclampsia'), ('GO_0007128', 'meiotic prophase I', 608, 'Preterm'), ('GO_0007567', 'parturition', 616, 'delivery'), ('UBERON_0022293', 'reproductive gland secretion', 940, 'intrauterine'), ('GO_0007565', 'female pregnancy', 978, 'gestational'), ('CHEBI_27300', 'vitamin D', 1147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1222, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 1254, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1254, 'Vitamin D'), ('GO_0007128', 'meiotic prophase I', 1440, 'Preeclampsia'), ('GO_0007128', 'meiotic prophase I', 1496, 'Preterm'), ('GO_0007567', 'parturition', 1504, 'delivery'), ('UBERON_0022293', 'reproductive gland secretion', 1837, 'intrauterine'), ('GO_0007565', 'female pregnancy', 1875, 'gestational')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4417995	4/2015	S188-PMC4417995	['ADDITIONAL STUDIES, with adequate sample size, dose adjustment based on target Serum Vitamin D levels, longer duration of treatment, standardization of ad severity assessment, and adequate correction for CONFOUNDING FACTORS such as sun/uvb exposure and Food Intake, ARE CURRENTLY MUCH NEEDED.']	[('FUTURE_WORK', 0), ('PROBLEM_COMPLICATION', 204), ('FUTURE_WORK', 266), ('FUTURE_WORK', 270)]	4	[('UBERON_0001977', 'blood serum', 79, 'serum'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33290', 'food', 253, 'food'), ('GO_0007631', 'feeding behavior', 253, 'food intake')]
PMC4427001	4/2015	S43-PMC4427001	['subjects\nto avoid the CONFOUNDING FACTOR of seasonal variation of Vitamin D levels, the recruitment of study subjects was confined to women whose 24–30th weeks of Gestation (i.e., the first, Midgestational Blood sampling) spanned winter months (i.e., january, february, and march).']	[('PROBLEM_COMPLICATION', 22)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'gestation'), ('GO_0007507', 'heart development', 191, 'midgestational'), ('UBERON_0000178', 'blood', 206, 'blood')]
PMC4448820	5/2015	S239-PMC4448820	['in vivo data for Vitamin A– and Vitamin D–DEPENDENT induction of Tregs in Humans are EMERGING but are EXTREMELY DIFFICULT to establish methodologically BECAUSE of the LIKELY need to obtain biopsied materials (144–146).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 102), ('DIFFICULT_TASK', 112), ('PROBLEM_COMPLICATION', 152), ('PROBABLE_UNDERSTANDING', 167)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 65, 'Tregs'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'humans')]
PMC4448820	5/2015	S782-PMC4448820	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● accurate and stable biomarkers of vad\n● EFFECT of Vitamin A supplementation on inflammation and inflammatory markers\n● mechanisms behind the variable clinical outcomes SEEN as a result of the IMPACT of Vitamin A on the different Immune Responses\n● EFFECT of Vitamin A supplementation on neonates and infants <6 mo\n● INFLUENCE of zinc status on vaccine response\n● other CONFOUNDERS in the zinc–vaccine response ASSOCIATION (age, sex, degree of zinc deficiency, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 374), ('PROBLEM_COMPLICATION', 427), ('SUPERFICIAL_RELATIONSHIP', 468)]	7	[('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin A'), ('GO_0006955', 'immune response', 287, 'immune responses'), ('UBERON_0002405', 'immune system', 287, 'immune'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin A')]
PMC4452099	6/2015	S96-PMC4452099	['ANOTHER POTENTIAL REASON WHY we DID NOT detect EFFECTS of early exposure to Vitamin D fortification on later t1d risk MAY BE RELATED to statistical power ISSUES [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('EXPLICIT_QUESTION', 25), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 125), ('PROBLEM_COMPLICATION', 154)]	9	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4452099	6/2015	S100-PMC4452099	['all of these FACTORS, which in DIFFERENT ways MAY BE RELATED to either Vitamin D intake and/or t1d risk, can be ASSUMED to be balanced between the Individuals from the various exposure groups, and THEREFORE CONFOUNDING is not to be expected.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 197), ('PROBLEM_COMPLICATION', 207)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC4466139	6/2015	S106-PMC4466139	['these results SHOW a strong ROLE for supplementation in increasing 25Ohd levels and also that supplementation at 400 iu/die is INSUFFICIENT to provide an appropriate Vitamin D status in Pregnant women and their offsprings.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 28), ('PROBLEM_COMPLICATION', 127)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 67, '25OHD'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnant')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4516377	6/2015	S79-PMC4516377	['SOME STUDIES17,18,20that evaluated the ASSOCIATION of Calcium and Vitamin D with obesity SHOWED a cross-sectional design and it is IMPORTANT to CONSIDER the existence of SOME LIMITATIONS, especially REVERSE causality, AS the exposure and outcome are collected simultaneously.30moreover, it is IMPORTANT to TAKE INTO account that one of the STUDIES14DID not make adjustments for CONFOUNDING FACTORS in the statistical analyses, in addition to the SMALL sample size used by others,13,14which CAN lead to erroneous conclusions.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 199), ('PROBABLE_UNDERSTANDING', 218), ('IMPORTANT_CONSIDERATION', 293), ('IMPORTANT_CONSIDERATION', 306), ('INCOMPLETE_EVIDENCE', 340), ('PROBLEM_COMPLICATION', 378), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 490)]	15	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4499946	7/2015	S298-PMC4499946	['longer-term surveillance of the infant cohort will IDEALLY enable the assessment of OTHER IMPORTANT clinical outcomes (e.g., asthma, Neurodevelopment) that MAY be INFLUENCED by the NON-CLASSICAL ROLE of Vitamin D in immunoregulation and Extraskeletal Cellular Proliferation and Differentiation.']	[('IMPORTANT_CONSIDERATION', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 163), ('PROBLEM_COMPLICATION', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('GO_0007399', 'nervous system development', 133, 'neurodevelopment'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 237, 'extraskeletal'), ('GO_0030154', 'cell differentiation', 251, 'cellular proliferation ... differentiation')]
PMC4586450	10/2015	S545-PMC4586450	['it was also EVIDENT that relative intakes of OTHER IMPORTANT Nutrients such as Calcium and Vitamin A declined in the preschool years,23and this was DUE TO the children starting to Consume more energy-dense, Nutrient-poor Foods (table 6).']	[('PROBABLE_UNDERSTANDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('IMPORTANT_CONSIDERATION', 51), ('PROBLEM_COMPLICATION', 148)]	4	[('CHEBI_33284', 'nutrient', 61, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 79, 'calcium'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin A'), ('GO_0007631', 'feeding behavior', 180, 'consume'), ('CHEBI_33284', 'nutrient', 207, 'nutrient'), ('CHEBI_33290', 'food', 221, 'foods')]
PMC4598849	10/2015	S10-PMC4598849	['maternal Vitamin D deficiency during Pregnancy is a SIGNIFICANT PUBLIC HEALTH PROBLEM GLOBALLY78DUE to the combined EFFECTS of limited sunlight exposure, INADEQUATE intake, and additional growth NEEDS of the fetus.']	[('IMPORTANT_CONSIDERATION', 52), ('PROBLEM_COMPLICATION', 78), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 116), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy')]
PMC4598849	10/2015	S15-PMC4598849	['the CONFLICTING findings MAY BE DUE TO VARIATIONS of study designs including the Gestational weeks of Vitamin D testing, the cut-point of Vitamin D, ethnicity of the study population, Genetic variation and outcome variables.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('PROBLEM_COMPLICATION', 32), ('DIFFICULT_TASK', 39)]	4	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('SO_0000704', 'gene', 184, 'genetic')]
PMC4598849	10/2015	S60-PMC4598849	['ALTHOUGH the neonatal 25(Oh)D levels at Birth cannot fully represent the Vitamin D status during CRITICAL times of Gestation DUE TO a half-life of several weeks of 25(Oh)D34, IT was quite POSSIBLE that the neonates with lower or higher Cord Blood 25(Oh)D levels MAY also have lower or higher average levels of 25(Oh)D during the whole Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 97), ('PROBLEM_COMPLICATION', 125), ('ANOMALY_CURIOUS_FINDING', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('CHEBI_79189', 'D-ribofuranose-2,5-bisphosphate', 164, '25(OH)D34'), ('PR_000001177', 'D(2) dopamine receptor', 170, 'D34'), ('UBERON_0002240', 'spinal cord', 236, 'cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 253, 'D'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 316, 'D'), ('GO_0007565', 'female pregnancy', 335, 'pregnancy')]
PMC4600246	10/2015	S79-PMC4600246	['on THE BASIS of PREVIOUSLY PRESENTED data, Warfarin MAY increase Arterial calcifications and osteoporosis through the inhibition of Vitamin K. LARGER TRIALS SHOULD BE performed to FURTHER ELUCIDATE the negative long-term health CONSEQUENCES of warfarin and IF these CAN PERHAPS be PREVENTED through the institution of supplemental Vitamin K.\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 52), ('FUTURE_WORK', 143), ('FUTURE_WORK', 157), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 188), ('PROBLEM_COMPLICATION', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257), ('INCOMPLETE_EVIDENCE', 266), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 281)]	12	[('CHEBI_10033', 'warfarin', 43, 'warfarin'), ('UBERON_0001637', 'artery', 65, 'arterial'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin K')]
PMC4624803	10/2015	S85-PMC4624803	['adjustment was made for the covariates age of mother, smoking of mother, season of Birth january to march and season of Birth july to september.all childrenchildren with mothers Born in swedenestimate95% confidence limitsp-valueestimate95% confidence limitsp-valuemodel 1-0.77-2.32, 0.770.32-1.11-2.76, 0.530.18model 2-0.77-2.25, 0.700.30-1.08-2.77, 0.620.21model 3-1.00-2.40, 0.390.16-1.00-2.47, 0.460.18model 4-0.99-2.34, 0.360.15-1.11-2.66, 0.440.16\n\ndiscussion\nOUR STUDY FAILS to SUPPORT the HYPOTHESIS that low levels of Vitamin D during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 465), ('PROBLEM_COMPLICATION', 475), ('INCOMPLETE_EVIDENCE', 484), ('INCOMPLETE_EVIDENCE', 496), ('SUPERFICIAL_RELATIONSHIP', 564)]	5	[('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007567', 'parturition', 120, 'birth'), ('GO_0007567', 'parturition', 178, 'born'), ('CHEBI_27300', 'vitamin D', 526, 'vitamin D'), ('GO_0007565', 'female pregnancy', 543, 'pregnancy')]
PMC4624803	10/2015	S116-PMC4624803	['AS a CONSEQUENCE of the LIMITED statistical power, we cannot exclude that the MAY BE a small to medium sized ASSOCIATION between Vitamin D levels at Birth and a later diagnosis of adhd.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 109)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth')]
PMC4632418	10/2015	S126-PMC4632418	['thirdly, there is one more POINT that the OBSERVED ASSOCIATIONS between maternal Vitamin D status and the risk of adverse Pregnancy outcomes COULD BE AFFECTED by CONFOUNDING FACTORS, such as bmi and skin tone.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 150), ('PROBLEM_COMPLICATION', 162)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4934634	11/2015	S13-PMC4934634	['HOWEVER, the prevalence of Vitamin D deficiency is a subject of intense DEBATE, IN PART DUE TO DIFFERENCES of opinion regarding WHAT actually constitutes a “deficiency”.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('EXPLICIT_QUESTION', 128)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4934634	11/2015	S118-PMC4934634	['ALTHOUGH positive EFFECTS were seen, 41.7% of the participants in the intervention group and 83% in the placebo group remained Vitamin D deficient (using the endocrine society cutoff; 20.8% and 54.2%, respectively using iom guidelines) DUE TO the low intervention dose.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('PROBLEM_COMPLICATION', 236)]	3	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4934634	11/2015	S184-PMC4934634	['using dietary Intake data ALONE CAN be PROBLEMATIC SINCE uvb-induced skin Formation of Vitamin D CAN significantly alter Serum 25(Oh)D, THUS, dietary Intakes MIGHT not be a reliable INDICATOR of overall Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 32), ('PROBLEM_COMPLICATION', 39), ('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 51), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 182)]	9	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('GO_0009057', 'macromolecule catabolic process', 74, 'formation'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('GO_0007631', 'feeding behavior', 150, 'intakes'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4934634	11/2015	S212-PMC4934634	['SINCE THE study LOOKED AT the number of visits RATHER than confirmed diagnosis of infection, THIS STUDY SUGGESTS infant Vitamin D supplementation in addition to Prenatal supplementation MIGHT be BENEFICIAL in reducing health care visits for acute Respiratory infections.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory')]
PMC4934634	11/2015	S226-PMC4934634	['the long half-life and Storage Of 25(Oh)D in fat MAY pose PROBLEMS with regard to Vitamin D toxicity.']	[('INCOMPLETE_EVIDENCE', 49), ('PROBLEM_COMPLICATION', 58)]	2	[('GO_1990170', 'stress response to cadmium ion', 23, 'storage of 25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4934634	11/2015	S297-PMC4934634	['UNLIKE Folic Acid fortification of grain products, Vitamin D fortification has primarily focused on dairy products, POTENTIALLY missing certain populations DUE TO cultural practices or perceived or actual Lactose intolerance.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 116), ('PROBLEM_COMPLICATION', 156)]	3	[('CHEBI_30751', 'formic acid', 7, 'folic acid'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_17716', 'lactose', 205, 'lactose')]
PMC4934634	11/2015	S303-PMC4934634	['Vitamin D supplementation/fortification HAS also BEEN met with OPPOSITION [107] DUE TO CONCERNS that Vitamin D is a hormone and SHOULD BE treated as such including addressing efficacy, dose and side effects.']	[('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('PROBLEM_COMPLICATION', 80), ('PROBLEM_COMPLICATION', 87), ('FUTURE_WORK', 128)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4934634	11/2015	S305-PMC4934634	['OTHER CONCERNS are the INSUFFICIENT EVIDENCE to determine the EFFECTS of Vitamin D supplementation/fortification on bone health and fracture incidence and that fda RECOMMENDATIONS to include Vitamin D on Food labels MAY ENCOURAGE fortification of Vitamin D in products that would not otherwise necessarily be RECOMMENDED, and lastly, that there is SOME EVIDENCE for POSSIBLE adverse consequences to Vitamin D fortification [107].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 62), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 216), ('FUTURE_WORK', 220), ('FUTURE_WORK', 309), ('INCOMPLETE_EVIDENCE', 348), ('INCOMPLETE_EVIDENCE', 366)]	10	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33290', 'food', 204, 'food'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC4684854	12/2015	S1-PMC4684854	['at the same time, there has been a burgeoning PROBLEM with WIDESPREAD Vitamin D deficiency among populations of many developed nations.']	[('IMPORTANT_CONSIDERATION', 46), ('PROBLEM_COMPLICATION', 46), ('IMPORTANT_CONSIDERATION', 59)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4684854	12/2015	S3-PMC4684854	['ALTHOUGH immediate costs for obstetric COMPLICATIONS RELATED to Gestational Vitamin D insufficiency MAY BE modest, the short- and long-term costs for pediatric healthcare resulting from such Gestational COMPLICATIONS MAY BE enormous and present an enduring BURDEN on Healthcare systems.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 217), ('IMPORTANT_CONSIDERATION', 257)]	7	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'gestational'), ('UBERON_0004151', 'cardiac chamber', 267, 'healthcare')]
PMC4684854	12/2015	S49-PMC4684854	['the medical literature has achieved GENERAL CONSENSUS that Vitamin D levels throughout much of the globe, as reflected by population measurements of 25(Oh)D3Levels, are generally INADEQUATE [38].']	[('PROBABLE_UNDERSTANDING', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('PROBLEM_COMPLICATION', 179)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 149, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 155, 'D3levels')]
PMC4684854	12/2015	S54-PMC4684854	['these iom RECOMMENDATIONS for REQUIRED Vitamin D intake HAVE BEEN put into SERIOUS question [42], HOWEVER, AS a significant statistical ERROR HAS BEEN identified in the way their recommendations were arrived AT [43].']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 107), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 208)]	9	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4684854	12/2015	S62-PMC4684854	['studies on Reproductive outcomes RELATED to Vitamin D supplementation, HOWEVER, are inherently PLAGUED by a NUMBER OF common CONFOUNDERS which CLOUD the picture.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 125), ('INCOMPLETE_EVIDENCE', 143)]	6	[('GO_0000003', 'reproduction', 11, 'reproductive'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4684854	12/2015	S67-PMC4684854	['specific CONCERNS about several Vitamin D meta-analyses CAN account for the varying outcomes REPORTED from this type of research.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 93)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4684854	12/2015	S84-PMC4684854	['obesity presents a CONFOUNDING INFLUENCE in THIS discussion, however, AS a greater bmi is ASSOCIATED with lower Vitamin D levels as well as greater Insulin resistance and risk for Gestational diabetes.']	[('PROBLEM_COMPLICATION', 19), ('SUPERFICIAL_RELATIONSHIP', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('PR_000045358', 'insulin family protein', 148, 'insulin'), ('GO_0007565', 'female pregnancy', 180, 'gestational')]
PMC4684854	12/2015	S119-PMC4684854	['economic burden of Gestational Vitamin D deficiency\nthe economic IMPACT of Vitamin D deficiency as it RELATES to maternal-fetal health is DIFFICULT to objectively quantify AS INSUFFICIENT evidence has ACCUMULATED THUS FAR on the totality of short- and long-term sequelae of Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 102), ('DIFFICULT_TASK', 138), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 175), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 213)]	8	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4684854	12/2015	S140-PMC4684854	['the ONGOING personal health BURDEN ASSOCIATED with Gestational Vitamin D insufficiency throughout many parts of the world has the POTENTIAL to be ameliorated CONSIDERABLY by straightforward educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Pregnancy.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 28), ('PROBLEM_COMPLICATION', 28), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 130), ('ANOMALY_CURIOUS_FINDING', 158)]	6	[('GO_0007565', 'female pregnancy', 51, 'gestational'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'preconception'), ('GO_0007565', 'female pregnancy', 251, 'prenatal'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy')]
PMC4689556	12/2015	S151-PMC4689556	['the FINDINGS from our trial, the FIRST Prenatal Vitamin D intervention trial to report child health outcomes, SUGGEST that either the dosing regimen used in this study was INADEQUATE, OR that the RELATIONSHIP between Cord Blood 25(Oh) Vitamin D and child health SEEN in OBSERVATIONAL studies MAY BE RELATED to hidden CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 172), ('PROBLEM_COMPLICATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 196), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBLEM_COMPLICATION', 317)]	12	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0009472', 'axilla', 217, 'cord blood'), ('CHEBI_30778', 'gallic acid', 228, '25(OH)'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC4690051	12/2015	S76-PMC4690051	['using stepwise selection (0.20 for entry, 0.05 to stay) to remove the insignificant variables, we retained 25(Oh)D status in the model while assessing the following POSSIBLE CONFOUNDERS: race (aa or ea), maternal iq, use of tobacco products or Alcohol during Pregnancy, maternal dietary Intake of Vitamin D, age, pre-Pregnancy bmi, total number of completed Pregnancies, Gestational hypertension or Gestational diabetes, insurance status, level of maternal education, marital status, child’s age at cv2, and Gestational age at Birth.']	[('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 174)]	2	[('CHEBI_71657', 'versiconol acetate', 107, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 107, '25(OH)D'), ('CHEBI_30879', 'alcohol', 244, 'alcohol'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0007631', 'feeding behavior', 287, 'intake'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy'), ('GO_0007565', 'female pregnancy', 358, 'pregnancies'), ('GO_0007565', 'female pregnancy', 371, 'gestational'), ('GO_0007565', 'female pregnancy', 399, 'gestational'), ('GO_0007565', 'female pregnancy', 508, 'gestational'), ('GO_0007567', 'parturition', 527, 'birth')]
PMC4690051	12/2015	S170-PMC4690051	['DUE TO phlebotomy limits in infants and THE BURDEN of other candle procedures, this candle sub-study lacks repeated measures of 25(Oh)D status for participants and lacks individual assessments of Parathyroid hormone status or Vitamin D receptor ( vdr ) genotype.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 128, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 196, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4690051	12/2015	S171-PMC4690051	['the design also COULD NOT control for POTENTIAL CONFOUNDING by differences in sunscreen use, sun exposure (e.g., air pollution or outdoor lifestyles), culture, skin cover by clothing, or post-Natal Vitamin D intake via diet.']	[('DIFFICULT_TASK', 16), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 48)]	3	[('GO_0007567', 'parturition', 192, 'natal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC4691762	12/2015	S31-PMC4691762	['mothers who receive Antenatal Vitamin D supplementation will not be excluded BECAUSE in our setting, this has not been shown to be PROTECTIVE against Postnatal infant Vitamin D deficiency.15\n\nrandomisation\nrandomisation will be undertaken using a web-based randomisation system set up within the trial database (redcap).']	[('PROBLEM_COMPLICATION', 77), ('SUPERFICIAL_RELATIONSHIP', 131)]	2	[('GO_0007567', 'parturition', 20, 'antenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 150, 'postnatal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4691762	12/2015	S69-PMC4691762	["participant's Vitamin D status will be defined by their Blood 25Ohd3 level, AS: severely deficient <12.5\u2005nmol/l; moderately deficient 12.5–25\u2005nmol/l; mild deficiency 26–49\u2005nmol/l; sufficient ≥50\u2005nmol/l; and elevated >220\u2005nmol/l.23\nparent baseline questionnaire : to check that potential environmental and OTHER CONFOUNDING factors are balanced between the two randomisation groups, baseline parent questionnaires will collect data on: parental smoking, medication use, parental ancestry, ethnicity, education, employment, occupation, family history of allergy, use of supplements including Vitamin A, d and cod Liver oil, number of siblings; and pet ownership."]	[('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 305), ('PROBLEM_COMPLICATION', 311)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_63058', '(2R,3S)-EHNA', 62, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25OHD3'), ('CHEBI_27300', 'vitamin D', 590, 'vitamin A'), ('UBERON_0002107', 'liver', 611, 'liver')]
PMC4691762	12/2015	S113-PMC4691762	['restricting the trial to infants with Vitamin D deficiency would REQUIRE a smaller trial, HOWEVER it would be UNETHICAL to randomise these infants to placebo thereby not treating with Vitamin D. the use of Vitamin D supplements in the placebo group is ANOTHER POTENTIAL ISSUE HOWEVER we are collecting sufficient data regarding Feeding practices, Supplement use and sun exposure to account for this.']	[('FUTURE_WORK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('DIFFICULT_TASK', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 260), ('PROBLEM_COMPLICATION', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_16158', 'steroid sulfate', 347, 'supplement')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4719746	1/2016	S63-PMC4719746	['explanatory linear regression models were performed TO ASSESS the relationship between ethnicity and the concentration of 25(Oh)D, both at inclusion and in Gestational week 28, accounting for the following POTENTIAL CONFOUNDING FACTORS: Gestational week, age, parity, season, education, Vitamin D supplements and pre-Pregnancy bmi.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216)]	3	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007565', 'female pregnancy', 156, 'gestational'), ('GO_0007565', 'female pregnancy', 237, 'gestational'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy')]
PMC4719746	1/2016	S78-PMC4719746	['aincluding 3 women from usa and canada\nbincomplete data on the variables BECAUSE of MISSING values for 6–12 women\nat Gestational week 28, the proportion of south asian and middle eastern women who had used Vitamin D supplements ≥10\xa0μg/day over the past two weeks was higher than at Gestational week 15 ( p \u2009<\u20090.01 and p \u2009<\u20090.05, respectively).']	[('PROBLEM_COMPLICATION', 73), ('PROBLEM_COMPLICATION', 84)]	2	[('GO_0007565', 'female pregnancy', 117, 'gestational'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 282, 'gestational')]
PMC4719746	1/2016	S133-PMC4719746	['HOWEVER, direct comparison of 25(Oh)D values between studies are hampered by DIFFERENT methodologies such as INCONSISTENT definitions of Vitamin D deficiency, laboratory measurements and degree of adjustment for POSSIBLE CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 212), ('PROBLEM_COMPLICATION', 221)]	5	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4764019	1/2016	S12-PMC4764019	['INSTEAD, where i FOCUS HERE is on the nonskeletal CONSEQUENCES both of untreated rickets and of lesser degrees of Vitamin D inadequacy, OFTEN not clinically apparent and occurring at critical periods during maturation, in some instances well before the Life Stages when rickets is typically manifest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('PROBLEM_COMPLICATION', 50), ('PROBABLE_UNDERSTANDING', 136)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000104', 'life cycle', 253, 'life stages')]
PMC4764019	1/2016	S49-PMC4764019	['this is BECAUSE, EVEN IF there were no connection between the Vitamin D status and the observed Learning difficulty, the group of Pregnant women to be studied would HAVE TO BE placed and maintained on a Vitamin D status, which is recognized to be INADEQUATE on OTHER grounds (ie, <18 ng/ml) and THEREFORE productive of harmful outcomes.']	[('PROBLEM_COMPLICATION', 8), ('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('IMPORTANT_CONSIDERATION', 165), ('IMPORTANT_CONSIDERATION', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 261), ('PROBABLE_UNDERSTANDING', 295)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007612', 'learning', 96, 'learning'), ('GO_0007565', 'female pregnancy', 130, 'pregnant'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4770602	1/2016	S17-PMC4770602	['[9] WHEREAS, an INCREASED RISK for preeclampsia is REPORTED in an investigation when Serum Vitamin D levels decreased around 20 ng/ml after adjusting for CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('PROBLEM_COMPLICATION', 154)]	4	[('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4770602	1/2016	S77-PMC4770602	['THEREFORE, Calcium intake MAY CONFOUND an ASSOCIATION between maternal Vitamin D deficiency and preeclampsia RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 11, 'calcium'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC4778858	3/2016	S23-PMC4778858	['HOWEVER, PREVIOUS STUDIES on Birth weight outcomes and RISK of gdm among Vitamin D deficient mothers DID NOT adequately address rates of maternal obesity, used an inaccurate vitamin d assay, or studied neonates of varying Gestational ages, thus CONFOUNDING interpretation of results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 101), ('PROBLEM_COMPLICATION', 245)]	5	[('GO_0007567', 'parturition', 29, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational')]
PMC4778858	3/2016	S119-PMC4778858	['furthermore, supplementation of Vitamin D during Pregnancy CONFOUNDS the outcomes.']	[('PROBLEM_COMPLICATION', 59)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy')]
PMC4778858	3/2016	S124-PMC4778858	['a MAJOR strength of THIS PLANNED STUDY was its design to reduce POTENTIAL CONFOUNDERS of ASSOCIATIONS between maternal and Cord Blood Vitamin D levels and maternal bmi.']	[('IMPORTANT_CONSIDERATION', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 64), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 89)]	6	[('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4785305	3/2016	S20-PMC4785305	['results derived from Nutrient rct, specifically Vitamin D supplementation, SUFFER from several CONFOUNDING FACTORS RELATED to the baseline status, intake of OTHER Nutrients, such as calcium and proteins, and sun exposure, which are DIFFICULT to quantify accurately.']	[('IMPORTANT_CONSIDERATION', 75), ('PROBLEM_COMPLICATION', 95), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('DIFFICULT_TASK', 232)]	5	[('CHEBI_33284', 'nutrient', 21, 'nutrient'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33284', 'nutrient', 163, 'nutrients')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4811441	3/2016	S31-PMC4811441	['case-control STUDIES OFTEN have INSUFFICIENT or no matching, GENERATING CONCERNS about CONFOUNDING AS VARIATIONS in Vitamin D status ASSOCIATED with season, skin pigmentation and lifestyle factors are known [15].']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('PROBLEM_COMPLICATION', 32), ('PROBABLE_UNDERSTANDING', 61), ('PROBLEM_COMPLICATION', 72), ('PROBLEM_COMPLICATION', 87), ('PROBABLE_UNDERSTANDING', 99), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 133)]	9	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4848664	4/2016	S131-PMC4848664	['development of the Folic Acid ul was BASED ON EVIDENCE of masking of Vitamin B-12 deficiency anemia, and THUS, CONCERNS about the Folic Acid ul are ONLY applicable to those with a Vitamin B-12 deficiency and not to the general population.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 105), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 148)]	7	[('CHEBI_30751', 'formic acid', 19, 'folic acid'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 69, 'vitamin B-12'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 180, 'vitamin B-12')]
PMC4896250	4/2016	S420-PMC4896250	['after adjustment for CONFOUNDING FACTORS, including age, smoking, alcohol drinking, exercise, and Vitamin D levels, high bmi (≥30 kg/m2) (or = 4.241, 95% ci: 1.60–11.24), high wc (≥80 cm) (or = 2.062, 95% ci: 1.08–3.94), and high bf percentage (q4) (or = 2.073, 95% ci: 1.22–3.52) were shown to be significantly ASSOCIATED with ad in young Adult women.']	[('PROBLEM_COMPLICATION', 21), ('SUPERFICIAL_RELATIONSHIP', 312)]	2	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0007023', 'adult organism', 340, 'adult')]
PMC4896250	4/2016	S6132-PMC4896250	['SINCE THESE studies were very HETEROGENEOUS and the retrospective or the observational cohort studies, large randomized controlled TRIALS ARE NEEDED to determine WHETHER Vitamin D supplementation MAY BE beneficial in the PREVENTION of ar.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('DIFFICULT_TASK', 30), ('FUTURE_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 221)]	7	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4998950	4/2016	S14-PMC4998950	['we considered other parental characteristics described below (also seetable 1) as POTENTIAL CONFOUNDERS or mediators BASED ON their ASSOCIATIONS with asd and Vitamin D deficiency.5,8,9\n\ncaption (table-wrap): table 1\nstudy population characteristics in relation to lifetime maternal history of diagnosed Vitamin D deficiencymaternal history of Vitamin D deficiencycharacteristicnoyes p allindividuals, n (%)509 092 (99.9)547 (0.1)509 639 (100.0)cases of asd with intellectual disability, n (%)2463 (0.5)13 (2.4)<0.00012476 (0.5)cases of asd without intellectual disability, n (%)7396 (1.4)10 (1.8)0.467406 (1.4)male (%)51.352.60.5151.3maternal age, years: mean29.928.5<0.000129.9paternal age, years: mean32.834.0<0.000132.8maternal country of Birth (%)\u2003sweden76.319.2<0.000176.2\u2003europe8.34.60.0028.3\u2003outside europe12.838.9<0.000112.9\u2003sub-saharan africa2.637.3<0.00012.6lowest quintile of disposable family income (%)14.835.6<0.000114.8elementary maternal education (%)15.643.1<0.000115.6elementary paternal education (%)16.832.7<0.000116.8born small for Gestational age (%)2.53.70.092.5premature Birth (<37 weeks, %)5.96.20.075.9maternal history of neuropsychiatric disorder (%)a2.49.3<0.00012.4paternal history of neuropsychiatric disorder (%)a2.02.00.982.0maternal history of affective disorder (%)b15.436.8<0.000115.4paternal history of affective disorder (%)b8.110.80.028.1maternal history of epilepsy (%)1.01.50.251.0paternal history of epilepsy (%)1.00.70.521.0\nparental histories of neuropsychiatric disorder include any in-patient or secondary care out-patient record of diagnosed non-affective psychosis, bipolar disorder, attention-deficit hyperactivity disorder, asd, or intellectual disability.']	[('INCOMPLETE_EVIDENCE', 82), ('PROBLEM_COMPLICATION', 92), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 132)]	5	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin D'), ('GO_0007567', 'parturition', 742, 'birth'), ('GO_0007565', 'female pregnancy', 1053, 'gestational'), ('GO_0007567', 'parturition', 1095, 'birth')]
PMC4998950	4/2016	S38-PMC4998950	['indeed, diagnosed maternal Vitamin D deficiency CO-OCCURRED with such FACTORS including parental psychiatric histories10(including depression, a PROXY also for in utero exposure to Antidepressants, shown to, RATHER than the underlying disorder, increase the risk of asd),11immigration status3and disadvantageous social position.8hence, residual CONFOUNDING CANNOT BE ruled out.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('PROBLEM_COMPLICATION', 345), ('DIFFICULT_TASK', 357)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 181, 'antidepressants')]
PMC4998950	4/2016	S44-PMC4998950	['this DISCREPANCY MIGHT be DUE TO a limited range of exposure in children of immigrant mothers, AS the majority of children and Pregnant mothers with migrant background have neonatal/Gestational Vitamin D deficiency, ACCORDING TO RECENT swedish REPORTS.6,11\ncausality cannot be inferred from our study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('PROBLEM_COMPLICATION', 26), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 244)]	7	[('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('GO_0007565', 'female pregnancy', 182, 'gestational'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC5035678	4/2016	S142-PMC5035678	['THUS, the effectiveness of longer periods of supplementation with Vitamin D is DOUBTFUL.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 79)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5035678	4/2016	S158-PMC5035678	['regarding the predicted prevalence of 35%, the DETECTED incidence of dysglycemia (31%) MIGHT have led to an UNDERESTIMATION of the IMPACT of Vitamin D in our study.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 87), ('PROBLEM_COMPLICATION', 108), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4859539	5/2016	S10-PMC4859539	['the LACK OF association between Vitamin D status and Cathelicidin in THIS STUDY MAY BE DUE TO the NARROW RANGE in OBSERVED 25(Oh)D values and WARRANTS ADDITIONAL STUDIES for further observation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 87), ('PROBLEM_COMPLICATION', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 142), ('FUTURE_WORK', 151)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 53, 'cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D')]
PMC4889866	5/2016	S91-PMC4889866	['the REASONS for various CONFLICTING results MIGHT be DUE TO DIFFERENCES in the study designs, age of the study population, definition of clinical outcomes, and also DISPARITIES in the assessment of Vitamin D concentration (use of maternal Blood or Cord Blood).']	[('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 44), ('PROBLEM_COMPLICATION', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('IMPORTANT_CONSIDERATION', 165)]	7	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000178', 'blood', 239, 'blood'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S116-PMC4889866	['SINCE the MAJORITY of our participants were Vitamin D deficient, IT IS POSSIBLE that higher Serum levels MIGHT be REQUIRED to reach optimal PROTECTIVE EFFECT to result in significant clinical DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4897157	5/2016	S148-PMC4897157	['third, we COULD NOT directly examine the RELATIONSHIP between Vitamin D status and allergic disease prevalence BECAUSE Serum Vitamin D levels were NOT RECORDED.']	[('DIFFICULT_TASK', 10), ('SUPERFICIAL_RELATIONSHIP', 41), ('PROBLEM_COMPLICATION', 111), ('ANOMALY_CURIOUS_FINDING', 147), ('FULL_UNKNOWN', 147)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4903143	5/2016	S87-PMC4903143	['Vitamin D\nthere is general CONSENSUS in the medical literature that the Vitamin D status of many Individuals and population groups throughout much of the world (as reflected by population measurements of Serum 25(Oh)D levels) is INSUFFICIENT for OPTIMAL health [74].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('PROBABLE_UNDERSTANDING', 27), ('PROBLEM_COMPLICATION', 229), ('IMPORTANT_CONSIDERATION', 246)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 97, 'individuals'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 210, '25(OH ... D')]
PMC5084734	5/2016	S28-PMC5084734	['gaps in Nutrient intake at this age are GENERALLY greatest for iron and zinc (vitta & dewey2013), BUT OTHER Nutrients MAY BE PROBLEMATIC (such as calcium, Vitamin A and certain b Vitamins) DEPENDING ON the types of foods consumed (dewey2013).']	[('PROBABLE_UNDERSTANDING', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189)]	6	[('CHEBI_33284', 'nutrient', 8, 'nutrient'), ('CHEBI_33284', 'nutrient', 108, 'nutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 179, 'vitamins'), ('PR_000027594', 'histone H3', 179, 'vitamins')]
PMC4930210	7/2016	S21-PMC4930210	['a RECENT systematic REVIEW of Vitamin D supplementation in Pregnancy CONCLUDED that EVIDENCE is currently INSUFFICIENT TO SUPPORT DEFINITE clinical RECOMMENDATIONS regarding Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 106), ('PROBLEM_COMPLICATION', 106), ('PROBABLE_UNDERSTANDING', 130), ('FUTURE_WORK', 148)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4930210	7/2016	S26-PMC4930210	['we RECENTLY SHOWED that not separating out Plasma 3-epi-25-hydroxycholecalciferol (3-Epi-25(Oh)D3) from Vitamin D status calculation UNDERESTIMATES the classification of Pregnant women and their newborns at risk for Vitamin D insufficiency (>75 nmol/l) [13].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBLEM_COMPLICATION', 133)]	3	[('UBERON_0001969', 'blood plasma', 43, 'plasma'), ('CHEBI_76629', '2-lysophosphatidic acid', 83, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 95, 'D3'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnant'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4930210	7/2016	S135-PMC4930210	['OUR FINDINGS are SUPPORTIVE of a GROWING body of LITERATURE SUGGESTING that the RECOMMENDED dose of Vitamin D during Pregnancy is INADEQUATE in preventing Vitamin D deficiency/insufficiency [26].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('FUTURE_WORK', 80), ('IMPORTANT_CONSIDERATION', 130), ('PROBLEM_COMPLICATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4944244	7/2016	S28-PMC4944244	['THEREFORE, it is NECESSARY to determine the PREVALENCE of hypovitaminosis D among Pregnant women and assess its risk FACTORS to overcome the PROBLEMS caused by lack of Vitamin D.\n\nmethods\n\nsubjects and sampling\na cross-sectional study was conducted in petaling district, selangor.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 141), ('PROBLEM_COMPLICATION', 141)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 74, 'D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4944244	7/2016	S107-PMC4944244	['the low Vitamin D status in tehran was PROBABLY DUE TO wearing of full dress and veil among all women, regardless of race and religion.']	[('PROBABLE_UNDERSTANDING', 39), ('PROBLEM_COMPLICATION', 48)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D')]
PMC4944244	7/2016	S118-PMC4944244	['LACK of Vitamin D was not found in Pregnant women who consumed Antenatal Vitamin supplements.']	[('PROBLEM_COMPLICATION', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('GO_0007567', 'parturition', 63, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 73, 'vitamin')]
PMC4944244	7/2016	S123-PMC4944244	['this was DUE TO ONLY 11.1\xa0% respondents took Vitamin D supplements or Antenatal Vitamin supplements containing Vitamin D in the first Trimester.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007567', 'parturition', 70, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 80, 'vitamin'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 134, 'trimester')]
PMC4944244	7/2016	S129-PMC4944244	['our main PROBLEM is the variation in the definition of Vitamin D deficiency.']	[('PROBLEM_COMPLICATION', 9)]	1	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4969253	8/2016	S90-PMC4969253	['circulating levels of Vitamin A (Retinol), Retinyl Esters, or ra do NOT NECESSARILY REFLECT the Retinoid status of target cells, SINCE activation of ra signaling depends on a COMPLEX interplay of the components of this pathway, including the presence of ra-synthesizing enzymes, ra receptors (rar, rxr), co-activators/co-repressors, and ra-Metabolizing enzymes.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 129), ('PROBLEM_COMPLICATION', 129), ('DIFFICULT_TASK', 175)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 33, 'retinol'), ('CHEBI_26523', 'reactive oxygen species', 43, 'retinyl esters'), ('CHEBI_26537', 'retinoid', 96, 'retinoid'), ('GO_0008152', 'metabolic process', 340, 'metabolizing')]
PMC4971719	8/2016	S95-PMC4971719	['we used stepwise linear regression analyses to better define the RELATIONSHIP between “low Vitamin D” and bdi score while adjusting for POTENTIALLY CONFOUNDING EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 136), ('PROBLEM_COMPLICATION', 148), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4971719	8/2016	S137-PMC4971719	['BECAUSE our study participants were drawn from a parent study looking at Omega-3 Fatty Acids (Dha and Epa) and their RELATIONSHIP to depression, and to adjust for other POTENTIAL CONFOUNDERS, we CONDUCTED a stepwise linear regression to BETTER UNDERSTAND the ASSOCIATION of Vitamin D with the bdi score.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 179), ('QUESTION_ANSWERED_BY_THIS_WORK', 195), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 259)]	7	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 73, 'omega-3 fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 94, 'DHA'), ('CHEBI_34733', 'EPN', 102, 'EPA'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
PMC4973215	8/2016	S29-PMC4973215	['to explore RELATIONSHIPS between race, Vitamin D levels and sga, we first EVALUATED race as a PREDICTOR of Vitamin D levels (sufficient or deficient) in cord Blood and ASSESSED for POTENTIAL CONFOUNDERS: medicaid status, bmi at Delivery, hypertension, maternal age and Prenatal Vitamin use.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 168), ('INCOMPLETE_EVIDENCE', 181), ('PROBLEM_COMPLICATION', 191)]	6	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 278, 'vitamin')]
PMC4973215	8/2016	S30-PMC4973215	['these results informed the next stage of analyses that examined race and Vitamin D levels with the outcome of sga by assessing POTENTIAL CONFOUNDERS: race, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery.']	[('INCOMPLETE_EVIDENCE', 127), ('PROBLEM_COMPLICATION', 137)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'delivery')]
PMC4973215	8/2016	S51-PMC4973215	['black infants with Vitamin D deficiency had 2.4 greater odds of sga (95% ci: 1.0, 5.8) after adjusting for maternal history of pih and maternal bmi, two significant CONFOUNDING variables in our model (table 3).']	[('PROBLEM_COMPLICATION', 165)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC4989298	8/2016	S237-PMC4989298	['NUMEROUS STUDIES have also evaluated the Intake of Vitamins (vit a, e, c) and Minerals (Mg, zn, Ca, p) [please NOTE that except for this chapter the data on Vitamin D is treated in a special section], BUT these often include methodological ERRORS, starting with the DIFFICULTY of FINDING a correct quantification of dietary Intakes of various Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('PROBLEM_COMPLICATION', 240), ('DIFFICULT_TASK', 266), ('INCOMPLETE_EVIDENCE', 280)]	6	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 78, 'minerals'), ('CHEBI_34829', 'Medrysone', 88, 'Mg'), ('CHEBI_32588', 'potassium chloride', 96, 'Ca'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 324, 'intakes'), ('CHEBI_33290', 'food', 343, 'foods')]
PMC4989298	8/2016	S375-PMC4989298	['conclusions\nALTHOUGH the AVAILABLE literature data SUGGEST the existence of a RELATIONSHIP between latitude and its consequent degree of ultraviolet radiation exposure, Vitamin D levels and the prevalence and severity of allergic diseases, the data of OBSERVATIONAL studies are encouraging, BUT CONTROVERSIAL and the ONLY available rct FAILS to SHOW an EFFECT on allergic disease prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 252), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 317), ('PROBLEM_COMPLICATION', 336), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 353)]	12	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4990268	8/2016	S295-PMC4990268	['as with all supplementation STRATEGIES to prevent the COMPLICATIONS ASSOCIATED with Micronutrient deficiencies, the IMPACT of supplementation in the Antenatal Period will DEPEND ON the overall Vitamin A status of the population and the special demands that Pregnancy makes on Vitamin A reserves.']	[('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('GO_0007567', 'parturition', 149, 'antenatal'), ('UBERON_0006721', 'alisphenoid bone', 149, 'antenatal period'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin A'), ('GO_0007565', 'female pregnancy', 257, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A')]
PMC4990268	8/2016	S298-PMC4990268	['one additional ISSUE for Vitamin A supplementation in Pregnancy is that high doses of Retinol are a WELL-KNOWN Teratogen IF provided early in Gestation[102].']	[('PROBLEM_COMPLICATION', 15), ('PROBABLE_UNDERSTANDING', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 86, 'retinol'), ('CHEBI_50117', 'phenylglyoxylyl-CoA', 111, 'teratogen'), ('GO_0007565', 'female pregnancy', 142, 'gestation')]
PMC4990268	8/2016	S1047-PMC4990268	['inter-Pregnancy intervals and outcomes of interest: kozuki[330] conducted a review/ meta-analysis based on 5 cohort studies (3 from the brazilian pelotas study [331–333], data from a Vitamin A study in zimbabwe[120], and a filipino study of Intrauterine growth restriction[334]), controlling for CONFOUNDERS.']	[('PROBLEM_COMPLICATION', 296)]	1	[('GO_0007565', 'female pregnancy', 6, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin A'), ('UBERON_0022293', 'reproductive gland secretion', 241, 'intrauterine')]
PMC4990268	8/2016	S1184-PMC4990268	['BUT current RECOMMENDED dose imposes IMPORTANT logistical DIFFICULTIES.antenatal vitamin aroutine supplementation not indicated BUT in Vitamin A deficient populations screening for night blindness and treating such cases with Vitamin A CAN be RECOMMENDED.Postnatal vitamin abenefit expected in Vitamin A deficient populations (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 37), ('DIFFICULT_TASK', 58), ('PROBLEM_COMPLICATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 236), ('FUTURE_WORK', 243)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('GO_0007567', 'parturition', 255, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin A')]
PMC4992225	8/2016	S232-PMC4992225	['the Vitamin D and control groups were SIMILAR regarding to general characteristics EXCEPT FOR two variables: unplanned Pregnancy and using other Supplements OUT OF THE STUDY’S PROTOCOL.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('PROBLEM_COMPLICATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 145, 'supplements')]
PMC4992225	8/2016	S281-PMC4992225	['also, SINCE more than 95\xa0% of the mothers had lower than 30\xa0ng/ml Serum 25-Hydroxyvitamin D concentration, it is NOT CLEAR IF the same results WOULD BE OBSERVED in mothers with higher levels of 25-Hydroxyvitamin D. THEREFORE, we SUGGEST FURTHER clinical TRIALS, using 2000\xa0iu Vitamin D on a larger population, mothers with high levels of depression, and high Serum 25-Hydroxyvitamin D concentrations.']	[('PROBLEM_COMPLICATION', 6), ('FULL_UNKNOWN', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('FUTURE_PREDICTION', 143), ('INCOMPLETE_EVIDENCE', 152), ('PROBABLE_UNDERSTANDING', 215), ('INCOMPLETE_EVIDENCE', 229), ('FUTURE_WORK', 237)]	8	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 72, '25-hydroxyvitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 194, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 365, '25-hydroxyvitamin D')]
PMC4997421	8/2016	S19-PMC4997421	['SINCE there is no de novo fetal Synthesis Of Vitamin A, the fetus relies completely on circulating maternal Vitamin A.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0)]	2	[('GO_0006557', 'S-adenosylmethioninamine biosynthetic process', 32, 'synthesis of vitamin A'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 53, 'A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 116, 'A')]
PMC4997421	8/2016	S95-PMC4997421	['THEREFORE, it is IMPERATIVE that women be Vitamin A sufficient prior to Becoming Pregnant in order to avoid depletion of Vitamin A stores DUE TO fetal and Lactation demands and subsequent ramifications to the mother or developing infant.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('PROBLEM_COMPLICATION', 138)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('GO_0007567', 'parturition', 72, 'becoming'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('GO_0007595', 'lactation', 155, 'lactation')]
PMC4997567	8/2016	S6-PMC4997567	['the RISK FACTORS were low socioeconomic status, insufficient family income, poor housing conditions, lack of exposure to sunlight DUE TO cultural practices, sole Breast feeding, and inadequate supplementation of Vitamin D to the children and the Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBLEM_COMPLICATION', 130)]	2	[('UBERON_0000310', 'breast', 162, 'breast'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnant')]
PMC5014971	8/2016	S4-PMC5014971	['a majority INDICATED that Vitamin D insufficiency was a PROBLEM in their patient population (68.4%) and that most of their Pregnant patients would BENEFIT from vitamin D supplementation (66.3%).']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 56), ('PROBLEM_COMPLICATION', 56), ('IMPORTANT_CONSIDERATION', 147)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 168, 'D')]
PMC5014971	8/2016	S20-PMC5014971	['in SOME populations, especially during the winter months in higher latitudes, the proportion of Pregnant women with INADEQUATE Vitamin D status MAY exceed 50% [13], DEPENDING ON whose definition of INADEQUATE is used.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('PROBLEM_COMPLICATION', 198)]	5	[('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5014971	8/2016	S21-PMC5014971	['there is SOME uncertainty over the extent of the us population that has INADEQUATE Vitamin D status DUE TO DISAGREEMENTS between experts as to WHAT constitutes INADEQUATE status.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 72), ('PROBLEM_COMPLICATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('EXPLICIT_QUESTION', 143), ('IMPORTANT_CONSIDERATION', 160)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5014971	8/2016	S24-PMC5014971	['other researchers have QUESTIONED this FINDING, citing both a CONCERN that circulating levels of 25-Oh-D at 20\u2009ng/ml have not been shown to be sufficient for bone health for all populations and that OTHER nonskeletal functions of Vitamin D POTENTIALLY IMPORTANT for health, which the iom report DISCOUNTS BASED ON INADEQUATE evidence, MAY yet be shown to be IMPORTANT and REQUIRE higher circulating levels of 25-Oh-D [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 252), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 305), ('ANOMALY_CURIOUS_FINDING', 311), ('IMPORTANT_CONSIDERATION', 314), ('PROBLEM_COMPLICATION', 314), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 358), ('IMPORTANT_CONSIDERATION', 372)]	15	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 97, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 409, '25-OH-D')]
PMC5014971	8/2016	S64-PMC5014971	['a majority responded that Vitamin D insufficiency was a PROBLEM in their patient population (68.3%) and that most of their patients would BENEFIT from taking a Vitamin D supplement (66.3%).']	[('IMPORTANT_CONSIDERATION', 56), ('PROBLEM_COMPLICATION', 56), ('IMPORTANT_CONSIDERATION', 138)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5014971	8/2016	S72-PMC5014971	['physicians that reported having read co 495 were more LIKELY to screen their Pregnant patients (36.9% always or often versus 17.0% that had not read co 495; p< 0.001) AS were physicians that reported that Vitamin D insufficiency was a PROBLEM in their patient population (32.8% always or often versus 9.7%; p = 0.004).']	[('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 167), ('IMPORTANT_CONSIDERATION', 235), ('PROBLEM_COMPLICATION', 235)]	4	[('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5014971	8/2016	S95-PMC5014971	["the greater the CONCERN is over their patients' Vitamin D status, the more LIKELY the physician is to RECOMMEND supplementation."]	[('PROBLEM_COMPLICATION', 16), ('PROBABLE_UNDERSTANDING', 75), ('FUTURE_WORK', 102)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5014971	8/2016	S97-PMC5014971	['the responding physicians were GENERALLY not supportive of screening all Pregnant women for Vitamin D status; EVEN among physicians that expressed a CONCERN regarding their patient population, less than half would screen most Pregnant patients.']	[('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 110), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149)]	4	[('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant')]
PMC5014971	8/2016	S98-PMC5014971	['there was a LACK OF CONSENSUS regarding the APPROPRIATE level of Vitamin D supplementation during Pregnancy and the value of circulating 25-Hydroxyvitamin D, below which there is CONCERN regarding Vitamin D insufficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 179), ('PROBLEM_COMPLICATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 137, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC5014971	8/2016	S131-PMC5014971	['there is CONCERN regarding Vitamin D insufficiency within their Pregnant patients.']	[('PROBLEM_COMPLICATION', 9)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant')]
PMC5024513	9/2016	S71-PMC5024513	['caption (table-wrap): table 2\n\ncharacteristics of included studiesstudy informationparticipantssupplementsmeasurementqualitystudycountrystudy designstudy groupsnumberageinclusion criteriaexclusion criteriasupplement type and dosenumber with available dataestimated compliance: n (%)data collection method (s)time period(s)quality ratingbaker et.al (2009) [23]ukcross-sectional studyna50014–18singleton Pregnancy, age 14–18, Gestational age\u2009<\u2009=20\xa0weeksinability to provide informed consent, preeclampsia, Clotting disorders, hiv/aids, haemoglobinopathies, diabetes, Renal disease, hypertension, multiple Gestations, history of 3=\u2009>\u2009previous Miscarriagespreconception folic acid49834 (6.9)24\xa0h recall (multiple)third Trimester+Folic Acid in early pregnancy498220 (44.2)Iron in early pregnancy49839 (7.8)multivitamins in early pregnancy49819 (3.8)Folic Acid only in 3rd trimester2905 (1.7)Iron and Folic Acid in 3rd trimester29013 (4.5)Iron only in 3rd trimester29042 (14.5)multivitamins in 3rd trimester2907 (2.4)castillo-duran et.al (2001) [43]chilerctzinc supplemented24916.4 (mean)beginning Prenatal visits before 20\xa0weeks Gestation, aged <19 at estimated due dateadolescents whose background included chronic diseases, Drug abuse, mental retardation, illiteracy or Pregnancy due to incest or rape20\xa0mg Zinc Sulphate dailyintervention group - 249at least 50\xa0% compliance24\xa0h Recall (multiple)second and third Trimester+placebo25840\xa0mg Iron Sulphateall participants - 507chan et.al (2006) [24]usarctcontrol group, 2 intervention groups excluded from review*2315–17enrolled before 20\xa0weeks Gestationhypertension, diabetes, Renal or Liver disease, alcohol or tobacco use, using medicines effecting Ca Metabolismno additional supplements reportedfood diary (weighing not mentioned)second and third Trimester−/+chang et.al (2003) [37]usaretrospective chart reviewna91812–17self-reported racial group as african-american; singleton Pregnancybirth results not AVAILABLE DUE TO abortion, Miscarriage or transfer of care90\xa0mg Carbonyl Iron daily plus additional up to 120\xa0mg for those classified as anaemic918not reportednot reportedsecond and third Trimester+dawson et.al (2000) [35]usarctone-a-day without iron2016–20aged 16–20, less than 16\xa0weeks Gestation, no Iron supplementation for previous 30\xa0dayshypertension; diabetes; other medical problems; haemoglobin <11\xa0g/dl; haematocrit <30\xa0%vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, Pantothenic Acid 10\xa0mg20not reportedvenous Blood samplesecond and third Trimester and Delivery−/+one-a-day with iron2018\xa0mg iron, vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, Niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, pantothenic Acid 10\xa0mg20derbyshire (2009) [39]ukcross-sectional studyna2015–19attending Antenatal classes or community clinicsincomplete diarynone reportedfood diary unweighedthird Trimester+gadowsky et.al (1995) [42]canadacross-sectional studyna5814–19not reportednot reportedfolic Acid mean 479\xa0μg/day5882\xa0%Venous Blood samplethird trimester+Elemental Iron mean 31.5\xa0mg/daycyanocobalamin (B12) mean 2.24\xa0μg/dgiddens et.al (2000) [27]usarct (subset from a larger study)na5913–18singleton Pregnancies, between 13 and 19\xa0weeks Gestationnot REPORTEDREPORTED that any contribution from Supplements was not included in analysisfood diary weighedmean over Pregnancy−/+ginde et.al (2010) [32]usasecondary analysis of cross sectional surveyna8413–19not reportednot reportedsome participants taking Vitamin D Supplementsnot reportednot reportedvenous Blood samplemean over Pregnancy+gutierrez et.al (1999) [28]usacross-sectional studyna4613–18self-identified ethnicity as mexican american, primigravida, 13–18 years of agehistory of Miscarriage or health problems, involved in competitive athletic performances or heavy exercise, planned to move away during study periodnone reported24\xa0h recall (single)second and third Trimester+iannotti et.al (2005) [36]usacross-sectional studyna8013–18self-reported racial group as african-american; singleton Pregnancynot reportednone reported10\xa0ml Venous Blood samplesecond and third trimesters+job et.al (1995) [41]australiacross-sectional studyna3513–19not reportednot reportednone REPORTED24\xa0h recallmean over Pregnancy+lee et.al (2013) [25]usacross-sectional studyna15613–18age 18 or under, carrying a single fetus, 12–30 weeks Gestation at recruitmentnot REPORTEDREPORTED that any CONTRIBUTION from Supplements was not included in analysis24\xa0h recall (multiple)<23\xa0weeks Gestation, 23–30 weeks Gestation and mean over Pregnancy+mcguire et.al.']	[('INCOMPLETE_EVIDENCE', 1954), ('PROBLEM_COMPLICATION', 1964), ('INCOMPLETE_EVIDENCE', 3401), ('INCOMPLETE_EVIDENCE', 4377), ('INCOMPLETE_EVIDENCE', 4553), ('SUPERFICIAL_RELATIONSHIP', 4579)]	6	[('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007565', 'female pregnancy', 424, 'gestational'), ('GO_0050817', 'coagulation', 504, 'clotting'), ('UBERON_0002113', 'kidney', 565, 'renal'), ('GO_0007565', 'female pregnancy', 603, 'gestations'), ('GO_0050788', 'sequestering of mercury', 640, 'miscarriagesPreconception'), ('GO_0009294', 'DNA mediated transformation', 715, 'trimester'), ('CHEBI_30751', 'formic acid', 725, 'Folic acid'), ('CHEBI_24870', 'ion', 767, 'Iron'), ('CHEBI_30751', 'formic acid', 844, 'Folic acid'), ('CHEBI_24870', 'ion', 886, 'Iron'), ('CHEBI_30751', 'formic acid', 895, 'folic acid'), ('CHEBI_24870', 'ion', 933, 'Iron'), ('GO_0007565', 'female pregnancy', 1092, 'prenatal'), ('GO_0007565', 'female pregnancy', 1124, 'gestation'), ('CHEBI_23888', 'drug', 1221, 'drug'), ('GO_0007565', 'female pregnancy', 1267, 'pregnancy'), ('CHEBI_10127', 'zonisamide', 1304, 'Zinc sulphate'), ('GO_0060033', 'anatomical structure regression', 1376, 'recall'), ('GO_0009294', 'DNA mediated transformation', 1410, 'trimester'), ('CHEBI_83530', 'atenolol-desisopropyl', 1436, 'iron sulphateAll'), ('GO_0051866', 'general adaptation syndrome', 1589, 'gestationHypertension'), ('UBERON_0002113', 'kidney', 1622, 'renal'), ('UBERON_0002107', 'liver', 1631, 'liver'), ('CHEBI_32588', 'potassium chloride', 1696, 'Ca'), ('GO_0008152', 'metabolic process', 1699, 'metabolismNo'), ('GO_0009294', 'DNA mediated transformation', 1795, 'trimester'), ('GO_0007605', 'sensory perception of sound', 1927, 'pregnancyBirth'), ('GO_0046660', 'female sex differentiation', 1981, 'miscarriage'), ('CHEBI_30255', 'sulfidocarbonate(.1-)', 2018, 'carbonyl iron'), ('GO_0009294', 'DNA mediated transformation', 2142, 'trimester'), ('GO_0007565', 'female pregnancy', 2242, 'gestation'), ('CHEBI_24870', 'ion', 2256, 'iron'), ('CHEBI_27300', 'vitamin D', 2403, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2421, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2438, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2455, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2474, 'thiamine'), ('CHEBI_16410', 'pyridoxamine', 2524, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2541, 'vitamin B'), ('CHEBI_7916', 'pantothenic acid', 2558, 'pantothenic acid'), ('UBERON_0000178', 'blood', 2601, 'blood'), ('GO_0009294', 'DNA mediated transformation', 2630, 'trimester'), ('GO_0007567', 'parturition', 2644, 'delivery'), ('CHEBI_27300', 'vitamin D', 2707, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2725, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2742, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2759, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2778, 'thiamine'), ('CHEBI_7542', 'neurotensin', 2814, 'niacin'), ('CHEBI_16410', 'pyridoxamine', 2828, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2845, 'vitamin B'), ('CHEBI_37527', 'acid', 2874, 'acid'), ('GO_0007567', 'parturition', 2950, 'antenatal'), ('GO_0009294', 'DNA mediated transformation', 3043, 'trimester'), ('CHEBI_37527', 'acid', 3145, 'Acid'), ('UBERON_0001638', 'vein', 3171, 'Venous'), ('UBERON_0000178', 'blood', 3178, 'blood'), ('CHEBI_4779', 'emedastine', 3206, 'Elemental'), ('CHEBI_24870', 'ion', 3216, 'Iron'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 3253, 'B12'), ('GO_0007565', 'female pregnancy', 3351, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3388, 'gestationNot'), ('CHEBI_33341', 'titanium atom', 3445, 'supplements'), ('GO_0007565', 'female pregnancy', 3513, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 3653, 'vitamin D'), ('CHEBI_46978', 'thiazinemonocarboxylic acid', 3663, 'supplementsNot'), ('UBERON_0000178', 'blood', 3705, 'blood'), ('GO_0007565', 'female pregnancy', 3727, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3887, 'miscarriage'), ('GO_0009294', 'DNA mediated transformation', 4074, 'trimester'), ('GO_0006915', 'apoptotic process', 4201, 'pregnancyNot'), ('UBERON_0001638', 'vein', 4241, 'Venous'), ('UBERON_0000178', 'blood', 4248, 'blood'), ('GO_0007565', 'female pregnancy', 4406, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4525, 'gestation'), ('CHEBI_33341', 'titanium atom', 4597, 'supplements'), ('GO_0007565', 'female pregnancy', 4669, 'gestation'), ('GO_0007565', 'female pregnancy', 4692, 'gestation'), ('GO_0007565', 'female pregnancy', 4716, 'pregnancy')]
PMC5024513	9/2016	S127-PMC5024513	['the summary results SHOW that there MAY BE areas of CONCERN in adolescent’s nutritional intake during Pregnancy, PARTICULARLY COMPARED to us RECOMMENDATIONS, with regard to calcium, Vitamin D, Vitamin E, Folate, potassium and magnesium.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 52), ('IMPORTANT_CONSIDERATION', 113), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 141)]	6	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC5051327	9/2016	S10-PMC5051327	['conclusions\nlow Vitamin D levels in early Pregnancy MAY BE ASSOCIATED with emergency caesarean section DUE TO suspected fetal distress and Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBLEM_COMPLICATION', 103)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC5051327	9/2016	S57-PMC5051327	['the daily RECOMMENDED intake of Vitamin D is 600\u2005iu/day in the usa5since the late 1990s in france, there HAVE been official RECOMMENDATIONS of 1000\u2005u vitamin d/day from 32\u2005weeks of Gestation or 100\u2005000 or 200\u2005000\u2005iu as a single dose at 32\u2005weeks in order to lower COMPLICATIONS in newborns.27\nCalcium Homeostasis In the Heart is IMPORTANT for the Contractility and function of the Heart.']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 105), ('FUTURE_WORK', 124), ('PROBLEM_COMPLICATION', 263), ('IMPORTANT_CONSIDERATION', 328)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 181, 'gestation'), ('CHEBI_31341', 'calcium dihydroxide', 292, 'Calcium'), ('GO_0007605', 'sensory perception of sound', 292, 'Calcium'), ('GO_0042592', 'homeostatic process', 300, 'homeostasis in'), ('GO_0007605', 'sensory perception of sound', 319, 'heart'), ('UBERON_0000948', 'heart', 319, 'heart'), ('GO_0006936', 'muscle contraction', 346, 'contractility'), ('GO_0007605', 'sensory perception of sound', 380, 'heart'), ('UBERON_0000948', 'heart', 380, 'heart')]
PMC5051327	9/2016	S70-PMC5051327	['SINCE PRIOR STUDIES had REPORTED on INCREASED RISK of emergency caesarean Delivery in RELATION to low Vitamin D, we used caesarean Delivery DUE TO suspected fetal distress AS a main outcome and Birth asphyxia as a secondary outcome.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('PROBLEM_COMPLICATION', 140), ('PROBABLE_UNDERSTANDING', 172)]	7	[('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 131, 'delivery'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC5085625	9/2016	S82-PMC5085625	['in our opinion, SOME DISCREPANCIES between the results of PREVIOUS STUDIES MAY result from LACK OF adjustment for Vitamin D supplementation and season of the Blood sampling.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 91)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood')]
PMC5028238	10/2016	S93-PMC5028238	['however, Vitamin D levels in slos patients are REPORTED to be low.55this COULD BE DUE TO many lifestyle factors that occur when a patient is SERIOUSLY ill with slos.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 73), ('PROBABLE_UNDERSTANDING', 82), ('PROBLEM_COMPLICATION', 82), ('IMPORTANT_CONSIDERATION', 141)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5045784	10/2016	S67-PMC5045784	['the ASSOCIATION between low Vitamin D levels and Respiratory morbidity as SEEN in older children and Adults MAY BE DUE TO DIFFERENT pathology than that SEEN in bpd, which is characterized by Alveolar simplification and impaired septation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('INCOMPLETE_EVIDENCE', 152)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 49, 'respiratory'), ('UBERON_0007023', 'adult organism', 101, 'adults'), ('UBERON_0003215', 'alveolus', 191, 'alveolar')]
PMC5064894	10/2016	S171-PMC5064894	['in secondary analyses, we will consider aggregation of multiple Vitamin D arms (e.g., group d and e), which will have the benefit of increasing the sample size; HOWEVER, for the a priori primary outcome analysis, we have decided to retain the separation of the groups (according to the design of the mdig trial) to LIMIT the POSSIBILITY of increasing a type ii ERROR IF a TRUE effect of the longer duration or higher-dose intervention were diluted by the lack OF effect of the other group(s).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('INCOMPLETE_EVIDENCE', 315), ('INCOMPLETE_EVIDENCE', 325), ('PROBLEM_COMPLICATION', 361), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('PROBABLE_UNDERSTANDING', 372), ('ANOMALY_CURIOUS_FINDING', 460)]	7	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5084041	10/2016	S18-PMC5084041	['POOR maternal Vitamin D status HAS also BEEN ASSOCIATED with Pregnancy COMPLICATIONS such as Preeclampsia [3], premature Birth [4] and infants Born small for Gestational age [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('PROBLEM_COMPLICATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 93, 'preeclampsia'), ('GO_0007567', 'parturition', 121, 'birth'), ('GO_0007567', 'parturition', 143, 'born'), ('GO_0007565', 'female pregnancy', 158, 'gestational')]
PMC5084041	10/2016	S22-PMC5084041	['SINCE data on Gestational Vitamin D status in populations living at latitudes without seasonality in cutaneous Vitamin D Synthesis are SCARCE, a season-corrected analysis is a way of investigating changes in 25(Oh)D during Pregnancy per se.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 135)]	2	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 111, 'vitamin D synthesis'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC5129897	10/2016	S151-PMC5129897	['as with all ESTIMATES, these have uncertainties, including the 25(Oh)D concentration–health outcome RELATIONS used; the ESTIMATES of economic BURDENS; whether reducing risk of specific diseases would translate into the same fraction of economic BURDEN; the extent to which changing risk-modifying risk factors such as smoking, alcohol Consumption, diet, and obesity modify the relative reduction due to higher 25(Oh)D concentration; and that the analysis omitted several Vitamin D–sensitive diseases and conditions BECAUSE of LIMITED UNDERSTANDING of the EFFECTS.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 245), ('PROBLEM_COMPLICATION', 515), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 555)]	8	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007631', 'feeding behavior', 335, 'consumption'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
PMC5129897	10/2016	S177-PMC5129897	['for example, 50% of the clinical trials with baseline 25(Oh)D concentration <50\xa0nmol/l FOUND beneficial EFFECTS of Vitamin D on BIOMARKERS of inflammation, WHEREAS ONLY 26% of those with higher baseline 25(Oh)D concentrations did.3the DIFFERENT results with respect to baseline 25(Oh)D concentration MAY BE DUE TO the LIMITED accuracy of clinical trials but COULD also be DUE TO CONSIDERABLY less BENEFIT for those with 25(Oh)D concentrations above 50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('ANOMALY_CURIOUS_FINDING', 156), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('INCOMPLETE_EVIDENCE', 300), ('PROBLEM_COMPLICATION', 307), ('INCOMPLETE_EVIDENCE', 318), ('INCOMPLETE_EVIDENCE', 358), ('PROBLEM_COMPLICATION', 372), ('ANOMALY_CURIOUS_FINDING', 379), ('IMPORTANT_CONSIDERATION', 397)]	15	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 203, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 278, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D')]
PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC5146866	12/2016	S0-PMC5146866	['prevalence and RISK factors for Vitamin D insufficiency and deficiency at Birth and ASSOCIATED outcome\n\nabstract\n\nbackground\noccurrence and consequence of Cord Blood (Cb) Vitamin D insufficiency/deficiency has not BEEN ADEQUATELY explored DESPITE rising CONCERN regarding THIS topic in pediatrics.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 214), ('ANOMALY_CURIOUS_FINDING', 239), ('PROBLEM_COMPLICATION', 254), ('QUESTION_ANSWERED_BY_THIS_WORK', 272)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('UBERON_0002240', 'spinal cord', 155, 'cord'), ('UBERON_0000178', 'blood', 160, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 167, 'CB'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5146866	12/2016	S11-PMC5146866	['background\ncharacterization of the Vitamin D status in the maternal-fetal-neonatal interface is clinically IMPORTANT BECAUSE of the increased rates of detection of Vitamin D insufficiency in Cord Blood (Cb) and the ASSOCIATED RISK for health COMPLICATIONS in infants and children [1,2], including but not limited to rickets [3], infectious and allergic diseases, and type 1 diabetes [4–6].']	[('IMPORTANT_CONSIDERATION', 107), ('PROBABLE_UNDERSTANDING', 117), ('PROBLEM_COMPLICATION', 117), ('SUPERFICIAL_RELATIONSHIP', 215), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 242)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0009472', 'axilla', 191, 'cord blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 203, 'CB')]
PMC5146866	12/2016	S54-PMC5146866	['the difference is DUE TO technical PROBLEMS with collection of 92 leftover cb samples, and INSUFFICIENT quantity of the specimen for testing of Vitamin D levels in three cb samples.']	[('PROBLEM_COMPLICATION', 18), ('PROBLEM_COMPLICATION', 35), ('PROBLEM_COMPLICATION', 91)]	3	[('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5146866	12/2016	S107-PMC5146866	['our data SHOULD ENCOURAGE pediatricians to supplement infants with Vitamin D ESPECIALLY CONSIDERING the REPORTED POOR COMPLIANCE with the aap’s RECOMMENDATIONS by both, pediatricians and parents [38].']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 113), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 118), ('FUTURE_WORK', 144)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5318550	2/2017	S95-PMC5318550	['the percentages of MISSING values within the population for analysis were lower than 20%, except for Maternal Pregnancy nutritional intake (29.9%), presence of maternal fever during Pregnancy (21.5%), maternal Pregnancy crp concentrations (34.9%), and maternal mid-Pregnancy and Cord Blood Vitamin D Plasma concentrations (23.8% and 45.9%).']	[('PROBLEM_COMPLICATION', 19)]	1	[('GO_0007618', 'mating', 101, 'maternal'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('GO_0007565', 'female pregnancy', 210, 'pregnancy'), ('GO_0007565', 'female pregnancy', 265, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 279, 'cord'), ('UBERON_0000178', 'blood', 284, 'blood'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 300, 'plasma')]
PMC5318550	2/2017	S157-PMC5318550	['moreover, certain VARIABLES have MISSING values of over 20%, for example, maternal nutrition and Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('PROBLEM_COMPLICATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC5372327	3/2017	S135-PMC5372327	['HOWEVER, DUE TO the randomised controlled study design our study will provide valuable data on the EFFECTS of Vitamin D substitution in populations with variable Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5368580	4/2017	S30-PMC5368580	['samples were analyzed for Retinol (Vitamin A), Tocopherol (Vitamin E), Thiamin (Vitamin B-1), riboflavin (Vitamin B-2), Nicotinamide (Vitamin B-3), Vitamin B-6, and Vitamin B-12 to examine 1 ) within-Feeding variation, 2 ) Circadian variation and contributions DUE TO subject variability, 3 ) acute short-term EFFECTS of maternal supplementation on milk Vitamin concentrations, and 4 ) the OPTIMAL time for collection to determine which Milk samples best represented the daily median Vitamin concentrations in Milk.']	[('PROBLEM_COMPLICATION', 261), ('SUPERFICIAL_RELATIONSHIP', 310), ('IMPORTANT_CONSIDERATION', 390)]	3	[('CHEBI_26536', 'retinoic acid', 26, 'retinol'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_27013', 'tocopherol', 47, 'tocopherol'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E'), ('CHEBI_26948', 'vitamin B1', 71, 'thiamin'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 88, 'B'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 90, '1'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin B'), ('CHEBI_17154', 'nicotinamide', 120, 'nicotinamide'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 134, 'vitamin B-3'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 148, 'vitamin B-6'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 200, 'feeding'), ('GO_0051216', 'cartilage development', 223, 'circadian'), ('CHEBI_33229', 'vitamin (role)', 354, 'vitamin'), ('UBERON_0001913', 'milk', 437, 'milk'), ('CHEBI_33229', 'vitamin (role)', 484, 'vitamin'), ('UBERON_0001913', 'milk', 510, 'milk')]
PMC5385921	4/2017	S18-PMC5385921	['we had the opportunity to explore the ASSOCIATION between developmental Vitamin D status and risk of asd, based on the same dutch Birth cohort in which we previously reported an ASSOCIATION between low mid-Gestational and neonatal Vitamin D concentrations and autistic traits.13within the cohort, we had access to an extensive set of POTENTIAL CONFOUNDING variables as well as the children’s individual-level Genome-wide genotype data.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 178), ('INCOMPLETE_EVIDENCE', 334), ('PROBLEM_COMPLICATION', 344)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth'), ('GO_0007565', 'female pregnancy', 206, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('SO_0001026', 'genome', 409, 'genome')]
PMC5405075	4/2017	S2-PMC5405075	['SINCE asthma is presented with high incidence in childhood and neonatal Vitamin D stores DEPEND on maternal Vitamin levels, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation was SUGGESTED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 108, 'vitamin'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'gestation')]
PMC5405075	4/2017	S9-PMC5405075	['SINCE asthma is presented with high incidence in childhood, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation HAS BEEN PROPOSED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
PMC5405075	4/2017	S54-PMC5405075	['HOWEVER, these clinical trials were BIASED by many LIMITATIONS, such as SMALL SIZE, Vitamin D administration ONLY in the last Trimester of Pregnancy, POSSIBLY INADEQUATE maternal dose administration, WHILE authors also acknowledged that they were NOT PRIMARY designed to assess the specific outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 150), ('IMPORTANT_CONSIDERATION', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('INCOMPLETE_EVIDENCE', 247)]	10	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 126, 'trimester'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy')]
PMC5426325	4/2017	S122-PMC5426325	['by comparing Individuals from entire adjacent Birth cohorts that were, or were not, exposed to extra Vitamin D from Margarine fortification Prenatally only, but all unexposed thereafter, we ASSUME that all POTENTIAL CONFOUNDERS are equally distributed in both groups, and HENCE that control for CONFOUNDING is not NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216), ('PROBABLE_UNDERSTANDING', 272), ('PROBLEM_COMPLICATION', 295), ('FUTURE_WORK', 314)]	6	[('NCBITaxon_1', 'root', 13, 'individuals'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_6784', 'mestranol', 116, 'margarine'), ('GO_0019230', 'proprioception', 140, 'prenatally')]
PMC5418719	5/2017	S10-PMC5418719	['DUE TO the POTENTIAL IMPACT of Vitamin D on many developmental processes in preterm infants, jobe et al.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5418719	5/2017	S12-PMC5418719	['HOWEVER, NO CONSENSUS RECOMMENDATION for Vitamin D deficiency was made specifically for preterm infants, BECAUSE FEW DATA on bone mineralization rates in utero are reported.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5418719	5/2017	S18-PMC5418719	['NEVERTHELESS, the APPROPRIATE amount of Vitamin D REQUIRED for optimal growth in vlbw is STILL IMPORTANT ISSUE to address.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 50), ('IMPORTANT_CONSIDERATION', 89), ('IMPORTANT_CONSIDERATION', 95), ('PROBLEM_COMPLICATION', 105)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5489519	6/2017	S94-PMC5489519	['SINCE there is no Trail toxicity demonstrated in vitro and in vivo treatment32,33, IT IS POSSIBLE that Trail Expression in the milk of mothers with Vitamin D deficiency COULD BE a compensatory mechanism to PROTECT infant health.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 18, 'TRAIL'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 103, 'TRAIL'), ('GO_0010467', 'gene expression', 109, 'expression'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5513133	7/2017	S6-PMC5513133	['conclusions\nthe included clinical trials do not show an independent effect of Vitamin D supplementation in PREVENTING pe; HOWEVER, ISSUES with dose, timing, and duration of supplementation HAVE NOT BEEN COMPLETELY ADDRESSED.']	[('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('PROBLEM_COMPLICATION', 131), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5513133	7/2017	S200-PMC5513133	['this MAY BE a result of ISSUES with study design and methodology, including LACK OF adjustment of KEY CONFOUNDING variables and methods of measuring Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBLEM_COMPLICATION', 24), ('PROBLEM_COMPLICATION', 76), ('IMPORTANT_CONSIDERATION', 98), ('PROBLEM_COMPLICATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5513133	7/2017	S204-PMC5513133	['residual CONFOUNDING and differences between groups MAY EXPLAIN the ASSOCIATION between Vitamin D deficiency and pe.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5513133	7/2017	S210-PMC5513133	['smoking MAY BE an IMPORTANT CONFOUNDER and SHOULD BE CONSIDERED in studies LINKING Vitamin D to pe.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 18), ('PROBLEM_COMPLICATION', 28), ('FUTURE_WORK', 43), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5513133	7/2017	S214-PMC5513133	['seasonality is also CONSIDERED a CONFOUNDER, particularly in studies RELATED to causal EFFECTS of Vitamin D on pe.']	[('INCOMPLETE_EVIDENCE', 20), ('PROBLEM_COMPLICATION', 33), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5537904	7/2017	S95-PMC5537904	['for the Vitamin D intake analysis, we excluded offspring who identified as a race/ethnicity other than non-hispanic white, non-hispanic black, or hispanic DUE TO small cell sizes.']	[('PROBLEM_COMPLICATION', 155)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D')]
PMC5537904	7/2017	S150-PMC5537904	['IT IS POSSIBLE that the differential ASSOCIATIONS between 25(Oh)D and Birthweight according to maternal bmi we OBSERVED are DUE TO VARIATIONS in overall energy intake or OTHER nutritional factors that are concomitant with increased Vitamin D intake and THUS increased 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 124), ('DIFFICULT_TASK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('PROBABLE_UNDERSTANDING', 253)]	7	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007596', 'blood coagulation', 70, 'birthweight'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D')]
PMC5540678	7/2017	S49-PMC5540678	['IN ORDER TO ASSESS CONFOUNDING arising from OTHER dimensions of diet, we additionally adjusted separately for maternal Intake of Vitamin E, zinc, Selenium, n -3 Polyunsaturated Fatty Acids (Pufas), N -6 Pufas, and total fruits and vegetables in Pregnancy [1,29–31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBLEM_COMPLICATION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44)]	4	[('GO_0007631', 'feeding behavior', 119, 'intake'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 146, 'selenium'), ('CHEBI_26203', 'polyprenol triphosphate', 161, 'polyunsaturated'), ('CHEBI_35366', 'fatty acid', 177, 'fatty acids'), ('CHEBI_86926', 'S a S b S', 190, 'PUFAs'), ('CHEBI_73643', 'Phe-Phe-Asp', 198, 'n -6 PUFAs'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC5546866	8/2017	S15-PMC5546866	['furthermore, ASSOCIATIONS between maternal Vitamin D status and obstetric COMPLICATIONS (4) and offspring Musculoskeletal Development (5–7) HAVE BEEN REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBLEM_COMPLICATION', 74), ('INCOMPLETE_EVIDENCE', 140)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0061375', 'mammillotectal axonal tract development', 106, 'musculoskeletal development'), ('UBERON_0002204', 'musculoskeletal system', 106, 'musculoskeletal')]
PMC5546866	8/2017	S134-PMC5546866	['BECAUSE the g Allele at rs10741657, which was more frequent in our population, was ASSOCIATED with lower 25(Oh)D following supplementation, it COULD BE POSTULATED that this Allele previously conferred an evolutionary advantage to prevent Vitamin D toxicity.']	[('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('SO_0001023', 'allele', 14, 'allele'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('SO_0001023', 'allele', 173, 'allele'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5638722	8/2017	S114-PMC5638722	['DUE TO the absence of Serum Vitamin D levels of the mothers who have premature Deliveries, the results obtained give ONLY INDIRECT DATA about maternal morbidities and Vitamin D. epidemiologic STUDIES ARE NEEDED for investigating the POSSIBLE maternal EFFECTS of low Vitamin D levels during Pregnancy.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 122), ('FUTURE_WORK', 192), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'deliveries'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC5664622	9/2017	S9-PMC5664622	['the FIRST REPORTS on Vitamin D insufficiency appeared in the 80s of the previous century but it was not until recently that the PROBLEM gained significant ATTENTION DUE TO the GROWING TENDENCY to stay indoors, avoid sun exposure, and use of sunscreen [2,3].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 10), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 165), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 184)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5664622	9/2017	S93-PMC5664622	['DUE TO the fact that weather conditions, including the increasingly common heat waves which prevent exposure to sun, remain beyond Human control, supplementation SEEMS TO BE the BEST method of preventing Vitamin D insufficiency.']	[('PROBLEM_COMPLICATION', 0), ('ANOMALY_CURIOUS_FINDING', 162), ('IMPORTANT_CONSIDERATION', 178)]	3	[('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5664622	9/2017	S98-PMC5664622	['the PROBLEM of low doses of Vitamin D in preparations for Pregnant women APPEARS TO BE GLOBAL.']	[('IMPORTANT_CONSIDERATION', 4), ('PROBLEM_COMPLICATION', 4), ('ANOMALY_CURIOUS_FINDING', 73), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant')]
PMC5664622	9/2017	S121-PMC5664622	['the ASSOCIATION between Vitamin D consumption and financial status WAS NOT INVESTIGATED, which is one of the LIMITATIONS of OUR STUDY BECAUSE that FACTOR MIGHT have AFFECTED the diet of the investigated population.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 124), ('PROBLEM_COMPLICATION', 134), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 165)]	9	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5659607	10/2017	S21-PMC5659607	['a recent meta-analysis SUGGESTED that INSUFFICIENT power DUE TO an OVERESTIMATION of the treatment effect MAY HAVE BEEN one of the ISSUES for the non-significance of the FINDINGS[11], BUT we HYPOTHESIZED that maternal 25(Oh)D level at trial entry MAY also have INFLUENCED the EFFECT of the Vitamin D supplementation[12].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 38), ('PROBLEM_COMPLICATION', 57), ('PROBLEM_COMPLICATION', 67), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 131), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 276)]	14	[('CHEBI_71657', 'versiconol acetate', 218, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 224, 'D'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC5659607	10/2017	S131-PMC5659607	['INTERPRETATION\nthis combined analysis of our two Vitamin D rcts SHOWED a significant 26% reduced risk of the primary end-point asthma/recurrent wheeze during the first 3 years of Life, which SUGGESTS that the non-significant/borderline significant trial responses OBSERVED in the individual intent-to-treat analyses were PARTLY due to LACK OF power caused by an OVERESTIMATION of the treatment effect, RATHER than lack of an intervention effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 321), ('INCOMPLETE_EVIDENCE', 335), ('ANOMALY_CURIOUS_FINDING', 340), ('PROBLEM_COMPLICATION', 362), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 402)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
PMC5659607	10/2017	S135-PMC5659607	['to explore that ISSUE, we performed the combined analyses stratified for the women’s 25(Oh)D level at trial entry, which SHOWED that the Vitamin D supplement resulted in a significantly reduced RISK of asthma/recurrent wheeze in the offspring of women with 25(Oh)D ≥ 30 ng/ml, BUT a much SMALLER and statistically non-significant EFFECT among women with 25(Oh)D < 30 ng/ml.']	[('PROBLEM_COMPLICATION', 16), ('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('INCOMPLETE_EVIDENCE', 288), ('SUPERFICIAL_RELATIONSHIP', 330)]	6	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 257, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 257, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5659607	10/2017	S142-PMC5659607	['our combined analysis also SUGGESTS that we MAY have used an INSUFFICIENT dosage of Vitamin D in both the trials.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 61), ('PROBLEM_COMPLICATION', 61)]	4	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5679631	11/2017	S36-PMC5679631	['data regarding POSSIBLE CONFOUNDERS and Vitamin D exposure through Supplement use was assessed from questionnaires sent to all parents at 34 weeks of Gestation, the time of Fecal sampling and 3 months Postpartum, respectively.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBLEM_COMPLICATION', 24)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 67, 'supplement'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('UBERON_0000922', 'embryo', 173, 'fecal'), ('GO_0007565', 'female pregnancy', 201, 'postpartum')]
PMC5682869	11/2017	S24-PMC5682869	['supplementation of Vitamin A is SUGGESTED to be restricted only to areas where Vitamin A deficiency is a substantial PUBLIC HEALTH PROBLEM.']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 131), ('PROBLEM_COMPLICATION', 131)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
PMC5706533	11/2017	S132-PMC5706533	['caption (fig)\n\nfig 5 \xa0proportion of all participants (n=8406) enrolled in eligible trials for which maternal and neonatal/infant outcomes were reported and met criteria for case definition and method of ascertainment; reported but did not meet minimum criteria; reported, but in manner that prevented inclusion of data in meta-analysis; missing because of loss of follow-up in trials for which outcome was reported for some participants or BECAUSE of apparent incomplete reporting of planned outcomes; or MISSING BECAUSE outcome was not assessed or not mentioned in published reports\n\nfuture projections of evidence based on registered ongoing/planned trials\nwe identified 35 registered trials of Prenatal Vitamin D with a total target enrolment of 12\u2009530 participants, of which 19 (54%) were completed but unpublished, 11 (31%) were ongoing or planned, and five (14%) had indeterminate status (fig 2; table a and fig a in appendix 11).']	[('PROBLEM_COMPLICATION', 440), ('PROBLEM_COMPLICATION', 505), ('PROBLEM_COMPLICATION', 513)]	3	[('GO_0007565', 'female pregnancy', 697, 'prenatal'), ('CHEBI_27300', 'vitamin D', 706, 'vitamin D')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC5707701	11/2017	S177-PMC5707701	['HOWEVER, our results INDICATED that neither Vitamin A nor E intakes from one 24-h dietary Recall was associated with Vitamin A and E in Human milk, which MAY BE DUE TO the inherent Intake variability of one single 24-h dietary Recall questionnaire, which DID NOT ALLOW for estimations of an Individual’s usual diet, and THEREFORE, it is LIKELY to under- OR overestimate some Nutrient intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 154), ('PROBLEM_COMPLICATION', 161), ('DIFFICULT_TASK', 255), ('ANOMALY_CURIOUS_FINDING', 259), ('PROBABLE_UNDERSTANDING', 320), ('PROBABLE_UNDERSTANDING', 337), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 354)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0060033', 'anatomical structure regression', 90, 'recall'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 131, 'E'), ('NCBITaxon_9606', 'Homo sapiens', 136, 'human'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0060033', 'anatomical structure regression', 227, 'recall'), ('NCBITaxon_1', 'root', 291, 'individual'), ('CHEBI_33284', 'nutrient', 375, 'nutrient')]
PMC5707701	11/2017	S183-PMC5707701	['secondly, LITTLE IS KNOWN about the levels of Vitamins A and E in maternal Plasma ASSOCIATED with the corresponding Milk, which would be better than dietary Intake to assess maternal Nutrient status, DUE TO the IMPOSSIBILITY to collect such samples in our research.']	[('FULL_UNKNOWN', 10), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBLEM_COMPLICATION', 200), ('PROBLEM_COMPLICATION', 211)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 46, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 61, 'E'), ('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('UBERON_0001913', 'milk', 116, 'milk'), ('GO_0007631', 'feeding behavior', 157, 'intake'), ('CHEBI_33284', 'nutrient', 183, 'nutrient')]
PMC5707701	11/2017	S184-PMC5707701	['thirdly, SINCE our design was a cross-sectional study, we COULD NOT collect DIRECT EVIDENCE about changes in Vitamins A and E with Lactation stages.']	[('PROBLEM_COMPLICATION', 9), ('DIFFICULT_TASK', 58), ('ANOMALY_CURIOUS_FINDING', 64), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 83)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 109, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 124, 'E'), ('GO_0007595', 'lactation', 131, 'lactation')]
PMC5707701	11/2017	S187-PMC5707701	['indeed, our results SHOWED that all of these milks, except for colostrum, did not meet an infant’s nutritional REQUIREMENT of Vitamin E. HOWEVER, we COULD NOT ESTIMATE the POSSIBLE supply of Vitamin A to the infant in the present study, DUE TO the LACKING detection of Retinol in Human milk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 237), ('FULL_UNKNOWN', 248)]	8	[('CHEBI_27300', 'vitamin D', 126, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 269, 'retinol'), ('NCBITaxon_9606', 'Homo sapiens', 280, 'human')]
PMC5732505	12/2017	S27-PMC5732505	['MANY of the FINDINGS regarding the RELATIONSHIP between Vitamin D deficiency and gdm are BASED ON case-control STUDIES, which MAY include a POTENTIAL selection BIAS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 140), ('PROBLEM_COMPLICATION', 160)]	8	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5732505	12/2017	S166-PMC5732505	['a CHALLENGE in PREVIOUS STUDIES on Vitamin D status and gdm HAS BEEN the LACK OF RELEVANT adjustments, for example adjustments for bmi and smoking status [6].']	[('DIFFICULT_TASK', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 73), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5812027	2/2018	S73-PMC5812027	['tobacco use and Vitamin D supplement use were also INVESTIGATED as POTENTIAL CONFOUNDERS BUT did not show any confounding effect and were THUS not included in the final MODELS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('PROBABLE_UNDERSTANDING', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC5812027	2/2018	S121-PMC5812027	['it is also POSSIBLE that the ASSOCIATIONS between fetal growth and maternal Vitamin D status are DUE TO residual CONFOUNDING or REVERSE CAUSATION.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBLEM_COMPLICATION', 97), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5827025	2/2018	S17-PMC5827025	['IN CONTRAST, the reports from randomized controlled trials INDICATE that Gestational Vitamin D supplementation CAN markedly decrease Pregnancy COMPLICATIONS including Preeclampsia and Pregnancy induced hypertension11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 143)]	4	[('GO_0007565', 'female pregnancy', 73, 'gestational'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 167, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC5838372	3/2018	S101-PMC5838372	['all these data CONFIRM that Vitamin D deficiency continues to be a PROBLEM in Pregnant women and their infants in turkey, DESPITE the introduction of the supplementation programme.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 122)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnant')]
PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
PMC5941617	5/2018	S47-PMC5941617	['1,25(Oh)2D measurement does not reflect Vitamin D status, OWING to the short half-life (4–6\xa0h) and the lower concentration (pg/ml vs. ng/ml).']	[('PROBLEM_COMPLICATION', 58)]	1	[('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 2, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5941617	5/2018	S49-PMC5941617	['the measurement of 25(Oh)D is DIFFICULT DUE TO its lipophilic nature, the binding to Vitamin D binding protein, the DIFFERENT circulating forms that also include epimers and isobars, and the standardization.']	[('DIFFICULT_TASK', 30), ('PROBLEM_COMPLICATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	3	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5941617	5/2018	S67-PMC5941617	['other italian data are present in literature, ALTHOUGH they SHOW SOME LIMITATIONS, regarding SMALL populations, analytic methods for 25(Oh)D, the season of recruitment, the prevalence of overweight/obesity, Vitamin D supplements, sunscreens, ethnicity, and uncovered areas of latitude.']	[('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 70), ('PROBLEM_COMPLICATION', 70), ('INCOMPLETE_EVIDENCE', 93)]	6	[('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 133, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5941617	5/2018	S160-PMC5941617	['VARIOUS STUDIES evaluated DIFFERENT regimens of Vitamin D supplementation, BUT comparison of results is COMPLEX DUE TO HETEROGENEITY in Vitamin D administration (dose, interval, and length of supplementation) and population enrolled (age, gender, ethnicity, body mass index, latitude of the country of residence, season of enrolment, and basal Vitamin D status).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('PROBLEM_COMPLICATION', 75), ('DIFFICULT_TASK', 104), ('PROBLEM_COMPLICATION', 112), ('DIFFICULT_TASK', 119)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC5941617	5/2018	S162-PMC5941617	['supplementation at 400\xa0iu/day for variable length (up to 12\xa0months) was USUALLY INSUFFICIENT in raising Serum 25(Oh)D levels >\u200930\xa0ng/ml [78,147–149,151–153,160–162], particularly in subjects with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 72), ('PROBLEM_COMPLICATION', 80)]	2	[('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 110, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC5941617	5/2018	S168-PMC5941617	['intermittent Vitamin D administration MAY BE CONSIDERED in case of reduced compliance with daily supplementation, BUT ACTUAL EVIDENCE IS INSUFFICIENT to RECOMMEND a PREFERRED doses and interval.']	[('INCOMPLETE_EVIDENCE', 38), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 137), ('FUTURE_WORK', 153), ('PROBABLE_UNDERSTANDING', 165)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC5941617	5/2018	S187-PMC5941617	['in cases of POOR compliance, supplementation with intermittent dosing (weekly or monthly doses for a cumulative monthly dose of 18000–30000\xa0iu of Vitamin D) can be CONSIDERED, starting from children aged 5–6\xa0years and PARTICULARLY during Adolescence.']	[('PROBLEM_COMPLICATION', 12), ('FUTURE_WORK', 164), ('IMPORTANT_CONSIDERATION', 218)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 238, 'adolescence')]
PMC5941617	5/2018	S232-PMC5941617	['the administration of a single large dose of Vitamin D\u2009>\u2009300000\xa0iu is not RECOMMENDED, BECAUSE MAY cause high risk of Vitamin D intoxication with hypercalciuria and hypercalcemia, AS CONFIRMED by RECENT STUDIES [191–195].']	[('FUTURE_WORK', 74), ('PROBLEM_COMPLICATION', 87), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 180), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 196)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5941617	5/2018	S594-PMC5941617	['HOWEVER, at PRESENT safety data in both the short- and the long-term of monthly or OTHER Vitamin D regimens LACK DUE TO the nature of the studies, especially in young children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5941617	5/2018	S639-PMC5941617	['in cases of POOR compliance, supplementation with intermittent dosing (weekly or monthly doses for a cumulative monthly dose of 18000–30000\xa0iu of Vitamin D) can be CONSIDERED, starting from children aged 5–6\xa0years and PARTICULARLY during Adolescence.']	[('PROBLEM_COMPLICATION', 12), ('FUTURE_WORK', 164), ('IMPORTANT_CONSIDERATION', 218)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 238, 'adolescence')]
PMC5941617	5/2018	S655-PMC5941617	['intermittent administration of Vitamin D MAY BE CONSIDERED in children and adolescents with POOR compliance with daily treatment (i.e.']	[('INCOMPLETE_EVIDENCE', 41), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 92), ('PROBLEM_COMPLICATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S664-PMC5941617	['HOWEVER, BECAUSE CURRENT EVIDENCE IS WEAK, we SUGGEST against Vitamin D administration as a therapy for Respiratory infections, beyond the correction of a DOCUMENTED Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 104, 'respiratory'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5941617	5/2018	S704-PMC5941617	['obesity is the cause and not the EFFECT of this ASSOCIATION BECAUSE of the deposition of Vitamin D in Adipose Tissue with consequent reduction in Serum 25(Oh)d levels.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 60)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 102, 'adipose tissue'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_30778', 'gallic acid', 152, '25(OH)')]
PMC5941617	5/2018	S706-PMC5941617	['we SUGGEST against Vitamin D administration to improve obesity-related COMPLICATIONS, given INCONSISTENT results and the SMALL NUMBER OF STUDIES.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 121)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
PMC5956785	5/2018	S64-PMC5956785	['in the most RECENT review of Vitamin D REQUIREMENTS, the iom CONCLUDED that there was INADEQUATE INFORMATION to make intake RECOMMENDATIONS in RELATION to OTHER biologic ROLES of vitamin d [19].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 97), ('FUTURE_WORK', 124), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 170)]	10	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5956785	5/2018	S126-PMC5956785	['2007 60°njia glucocorticoid treatedn\u2009=\u200962 (43)median 11.8 (4.6–17.9median 49\xa0nmol/l 16 (23%)\u2009≤\u200937.5\xa0nmol/losteoporosis is a CONCERN in Glucocorticoid treated children with jia.32% prescribed 400–800\xa0iu Vitamin D dailymean intake 316\xa0iu (range 44–1204\xa0iu).ohio, usa henderson et al.']	[('PROBLEM_COMPLICATION', 124)]	1	[('CHEBI_24261', 'glucocorticoid', 135, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC5956785	5/2018	S193-PMC5956785	['long-term, adequately powered randomized studies which control for CONFOUNDING variables (sun exposure, season, and Vitamin D intake) are REQUIRED to confirm a causative RELATIONSHIP between Vitamin D and disease activity.']	[('PROBLEM_COMPLICATION', 67), ('IMPORTANT_CONSIDERATION', 138), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC6011374	6/2018	S13-PMC6011374	['evidence SUGGESTS that Vitamin D deficiency is ASSOCIATED with a number of Pregnancy COMPLICATIONS including Preeclampsia (pe), Gestational diabetes mellitus (gdm) and spontaneous Preterm Birth (Sptb) [2–4].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 47), ('PROBLEM_COMPLICATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 109, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 128, 'gestational'), ('GO_0007565', 'female pregnancy', 180, 'preterm birth'), ('PR_000015390', 'sterol O-acyltransferase 2', 195, 'sPTB')]
PMC6011374	6/2018	S15-PMC6011374	['this MAY BE explained, IN PART, by INADEQUATE control of RELATED risk factors and CONFOUNDERS in statistical analyses, VARIATIONS between assays that measure Vitamin D and significant HETEROGENEITY between studied populations [6].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 23), ('PROBLEM_COMPLICATION', 35), ('SUPERFICIAL_RELATIONSHIP', 57), ('PROBLEM_COMPLICATION', 82), ('DIFFICULT_TASK', 119), ('DIFFICULT_TASK', 184)]	7	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC6011374	6/2018	S63-PMC6011374	['HOWEVER, after adjusting for maternal age, bmi, sei, smoking status and Alcohol consumption at 15\u2009±\u20091\xa0weeks’ Gestation, ethnicity, recreational walking and season, the women recruited in adelaide STILL had significantly lower Serum 25(Oh)D when compared with those in auckland (adelaide: 58.4\u2009±\u200950.3 vs. auckland: 70.2\u2009±\u200954.5\xa0nmol/l, p\u2009<\u20090.001) INDICATING the INFLUENCE of OTHER CONFOUNDERS not measured as part of the study on Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 373), ('PROBLEM_COMPLICATION', 379)]	6	[('CHEBI_30879', 'alcohol', 72, 'alcohol'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 232, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC6011374	6/2018	S111-PMC6011374	['lack of statistically significant associations with other Pregnancy complications MAY reflect the fact that this was a largely Vitamin D-replete population (>\u200972% with Serum 25(Oh)D\u2009>\u200950\xa0nmol/l) LIKELY DUE TO their residence latitude as low Serum 25(Oh)D was found in the scope ireland cohort [52].']	[('INCOMPLETE_EVIDENCE', 82), ('PROBABLE_UNDERSTANDING', 195), ('PROBLEM_COMPLICATION', 202)]	3	[('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 177, 'OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 247, '25(OH)D')]
PMC6039335	7/2018	S263-PMC6039335	['continuous dietary Vitamin A restriction during the late fattening phase is not RECOMMENDED because prolonged Vitamin A restriction MAY lead to health PROBLEMS and retard growth rate [130].']	[('FUTURE_WORK', 80), ('INCOMPLETE_EVIDENCE', 132), ('PROBLEM_COMPLICATION', 151)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin A')]
PMC6039335	7/2018	S265-PMC6039335	['a continuous supply of normal levels of dietary Vitamin A during the entire growth period MAY also result in poor marbling and qg, EVEN IF the growth rate were normal and no health PROBLEMS occurred.']	[('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('PROBLEM_COMPLICATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A')]
